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Neurodegenerative diseases describe a set of diseases caused by abnormalities 
while certain proteins are processed. These proteins accumulate in the nerve 
tissue and produce clinical manifestations. The main manifestation is Dementia. 
The most common type of dementia is Alzheimer’s disease, which affects 50-80% 
of the population [1]. Currently, this type of dementia is considered incurable and 
irreversible. For this reason, it is important to know all the information about this 
disease, so the more information we have, the better solution we can find and 
maybe with the passage of the time this disease can be curable and reversible.  
 
The technique PET can detect this type of diseases during the patient’s life. 
Furthermore, by means of this technique it has been observed that these diseases 
have several kinds of patterns according to the brain metabolism degradation. 
Normally, when a brain is affected by this kind of disease, the brain metabolism 
degradation begins in a specific area of the brain, but as the disease progresses 
this area can get bigger or affect other areas of the brain.  
 
The goal of this thesis is to analyze a set of PET scans from several people who 
have some kind of neurodegenerative disease, such as, Mild Cognitive Impairment 
(MCI) and Alzheimer’s Disease (AD). This analysis will allow us to obtain an order 
among the PET scans according to the affected areas in the brain, and will show 
the brain metabolism degradation in the development of Alzheimer’s disease. This 
order will be represented by an acyclic directed graph (ADG) that it will be 
visualized in an application. This application will get the set of PET scans and it will 
obtain the corresponding graph which will show the order of PET scans. 
Furthermore, in each node we will display complementary information about each 
PET scan. 
 
This application, it will not be used only by computer experts but also by unskilled 
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The neurodegenerative diseases constitute a set of diseases which manifest an 
inadequate process of certain proteins that appears in each cellular circuit. 
Using the technique PET it has been observed that this type of diseases have 
different kinds of patterns according to the brain metabolism degradation. In a 
brain affected by this kind of diseases it has been analyzed that the metabolism 
degradation begins at a specific region of the brain. As far as the disease 
progresses this region of the brain can get bigger or affect other regions in the 
brain. 
To analyze how the metabolism develops in a brain affected by this kind of 
diseases it is an important task and at the same time difficult. However, it can 
provide a lot of information about these diseases. The more information it knows 
about diseases evolution the better, so with all this, its early detection can be 
achieved. Moreover, it will avoid its progress and all this will help that these can be 
curable and reversible someday. Nowadays, some of them are still incurable and 
irreversible. 
The main goal of this thesis is to create an ordering on PET scans to decide for 
two scans, whether the brain metabolism degradation of one PET scan, is a 
progression of the other. This ordering will be then applied to arrange a set of PET 
scans which have Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD). 
This order will show how the brain metabolism degradation progresses for this kind 
of diseases. As a last step, to visualize this ordering an application will be 
implemented. This application will show the ordering of a given set of PET scans in 
a directed acyclic graph (DAG). Furthermore, it will also visualize additional 
information in each node of the graph about each PET scan. 
The application will have a friendly interface which allows people perform studies 
about neurodegenerative diseases; in particular, studies which are focused in 
analyze how the brain metabolism degradation progresses by some specific 
disease. Moreover, its design will offer facility to computers experts and even 
unskilled users will be able to use it. 
Once the study that is going to be performed in this project has been introduced, 
we will detail the parts which make up this work: Chapter 2 will define the 
neurodegenerative diseases and will explain the dementia with detail. Chapter 3 
will introduce information about PET technique which was used to obtain the 
analyzed images. Chapter 4 will deal with the typical psychological tests performed 
in this kind of studies. Chapter 5 will describe the set of images which we will use 
to make our study. All the process followed to obtain the ordering of PET scans 
and how this order has been visualized are shown and detailed in Chapter 6. The 
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performed experiments and the results to evaluate the corresponding graph are 
presented in Chapter 7. And finally, in Chapter 8 the conclusions about all the 











Bioinformatics is a research area which applies the information technology to the 
science of life. This thesis, as a project of Bioinformatics and Medical image, will 
perform a study about dementia progress from medical images which have Mild 
Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) by using 
computationally powerful techniques. 
To better understand these terms and obtain the necessary knowledge to perform 
this study, this chapter will provide a short description about neurodegenerative 
diseases and, with more detail, about dementia. It will explain causes and 
symptoms of dementia. Moreover, a classification about types of dementia will be 
also described. In this point, AD and MCI will be more detailed because these are 
the two types of diseases which will be analyzed in this project. 
 
2.1  Definition 
Neurodegenerative diseases are a set of diseases that are caused by an 
inadequate protein processing in cells. These proteins accumulate in the nerve 
tissue inside and outside of neurons causing the bad functioning of neurons and 
their posterior death because they lose their connections with other neurons [2]. 
These kinds of diseases are chronic and they steadily progress. These diseases 
are characterized by being a selective and symmetric loss of neurons in the 
sensory motor and cognitive systems. Although dementia is the main symptom of 
these diseases, it must not confuse with the normal ageing process because in the 
normal ageing process the loss of neurons is lower. 
Although not all neurodegenerative diseases cause dementia, this is considered 
the most common manifestation of this type of diseases. 
 
2.2  Dementia 
Dementia is not a specific disease but a descriptive term about collection of 
symptoms which produce a progressive loss of cognitive functions due to brain 
damage and disorders [3]. These symptoms can coexist with disorders of 
emotional control, social conduct and motivation.  
Dementia usually affects the parts of the brain which control memory, language, 





Figure 1: The parts of the brain which are affected by dementia. 
                   
2.2.1  Cause 
Some demographic factors, such as, age, sex, genetic predisposition, previous 
cerebral traumatisms, and the education level can increase the risk of dementia 
development. Nevertheless, the main causes of dementia are usually a set of 
neurodegenerative diseases; the clearest example is Alzheimer's disease (AD) [4]. 
These diseases are classified in degenerative and vascular diseases according to 
the effect in the impairment of cognitive process [5]. If the impairment is 
irreversible in the cognitive process, then dementia is caused by a degenerative 
disease. Although the clearest example is AD, there are others diseases which can 
also cause dementia, such as, Parkinson's disease, Huntington's chorea and 
frontotemporal dementia or Pick's disease [3]. 
On the other hand, if the impairment is caused by small strokes then dementia has 
a vascular cause. Though the brain damages are generally considered irreversible, 
patients could receive some medical treatment to avoid future strokes. As the mild 
cognitive impairment is a transitory state, its posterior evolution will determine if it 
is considered as a cause of dementia or not. 
 
2.2.2  Symptoms 
The dementia supposes the irreversible loss of intellectual capacities which 
include: memory, ability to express and communicate adequately, ability to 
organize daily life and to have normal life with autonomy. For this reason, in this 
point we will see how the progress of dementia affects these capacities.  
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The first capacity affected by dementia is memory. So, the first symptom is the 
forgetfulness. 
As stated before in point 2.2.1, the mild cognitive deterioration is a transitional 
state between the normal ageing and the development of dementia [6]. Although it 
does not always progress into a dementia state, in the case of doing so, its first 
symptoms will be minor problems with the thinking and memory capacities, but 
which do not interfere in the everyday life, and people suffering them are 
completely conscious of the forgetfulness they suffer [6]. 
In the early stages of dementia the symptoms begin to be visible. Patients ask the 
same question frequently, have personality and mood changes, misplace items 
and have some difficulty to find the name of familiar objects. 
In the intermediate stages of dementia, the symptoms are more distinguished and 
interfere in their care. Among these symptoms, we emphasize the following: 
patients need help to dress, to bath, they have difficulty to do basic tasks, such as, 
cooking, reading and writing, and they forget events in their life or details about 
recent events. In this stage, people can also have hallucinations and depressions.  
In the severe stages of dementia, patients depend absolutely from third people to 
do the most basic tasks of everyday life. They do not usually know who they are 
and sometimes they cannot even recognize their familiar members. 
Although there are a lot of symptoms which can be observed, in this point we have 




The dementia disorders can be classified on several ways. These classification 
schemes attempt to group disorders according to whether, they are progressive or 
not, or depending on the affected areas of the brain. 
The most frequently used classification is the following [3]: 
 The cortical dementia: is the dementia in which the brain damage mainly 
affects the cerebral cortex or exterior layer. This kind of dementia causes 
problems in memory, language, thinking and social conduct.  
 
 The subcortical dementia: is the dementia which affects the parts of the 
brain which are under the cortex. This type of dementia causes memory 
problems, a part from changes in emotions and movement. 
 
 The progressive dementia: this type of dementia makes worse over time 
and interferes in many cognitive functions. 
 
 The primary dementia: this dementia is not a result of another disease; for 
example, Alzheimer’s disease. 
 
 The secondary dementia: this dementia occurs as a result of physical 
disease or lesion, such as, vascular dementia. 
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Some types of dementia can fit into more of one classification. This is the case of 
Alzheimer's disease, which is treated as primary, cort ical and progressive 
dementia [3]. 
Then we see the MCI and AD more detailed, as well as, a short description about 
some of neurodegenerative diseases which also can cause dementia. 
 
MILD COGNITIVE IMPAIRMENT 
The Mild Cognitive Impairment (MCI) is a concept which describes a transitional 
state between the normal ageing and the development of dementia [6]. This term 
delimits a group of people who have a higher risk to develop dementia than that 
observed in the general population. 
The first symptom of MCI is forgetfulness, but the patients are conscious of this 
oblivion, and therefore, their everyday life is not affected. 
In the next figure, we can appreciate the brain metabolism degradation in the 
progress of dementia. So, on the left of figure 2, the PET scan shows normal levels 
of glucose metabolism, indicated in yellow and red. As we can observe in the 
others PET scans, the levels of glucose metabolism in the brain are decreases in 
patients with MCI (the PET scan in the middle of figure 2) and with AD (the PET 
scan on the right of figure 2). 
 
 
Figure 2: Comparing of levels of glucose metabolism with a Normal patient’s brain (left), a 
Mild cognitive impairment patient's brain (middle) and Alzheimer's disease patient's brain 
(right). 
                       
We have to take into account that the MCI is not a previous stage of AD or others 
diseases which can cause dementia. This is a transitional stage which can 
develop some kind of disease, which at the same time can cause dementia, or 
balance itself and it does not manifest any posterior disease. Therefore, the MCI 
is only a stage which can increase the risk to suffer some type of dementia in 




For this reason, we want to show in the next table a classification of several kinds 
of MCI, as well as, their associated alterations and possible associated disorders 




ALZHEIMER DISEASE  
Alzheimer's disease (AD) is the most common cause of dementia in elderly people. 
One out of every ten people older than 65 and, almost half of people over 85, 
suffer from Alzheimer's disease. In most people the symptoms of this disease turn 
up soon after 60 ages old and its average expectancy is 10 years [3] but this can 
change because this depends on the severity of the disease when the diagnostic is 
done. Currently for this disease there is not any curative treatment.  
Alzheimer's disease is a progressive, degenerative and irreversible disease which 
affects the brain cells and produces memory loss and other intellectual 
impediments. So, Alzheimer’s disease can be defined as a situation which 
produces a functional inability in the social and working context, sometimes even 
affecting familiar. 
This disease slowly attacks nerve cells in all parts of the brain, but especially in the 
hippocampus and the amygdala (at the bottom-left of figure 3), which are important 
parts of the limbic system that coordinate memory storage and recall, and the 
cerebral cortex (at the top-right of figure 3), the seat of higher-level thinking, 




      Cognitive disorders 
 
       Related disorders 
MCI amnesic  
 mild memory 
alteration 
 
 Alzheimer disease 
MCI diffuse  




 Alzheimer disease 
 Vascular dementia 











 Lewy body dementia 
 Vascular dementia 
 Primary progressive 
aphasia 
 Parkinson disease 
 Alzheimer disease 





Figure 3: The parts of the brain which are affected in the development of Alzheimer’s disease. 
 
Even though, the alteration of the memory is the main feature to diagnose this 
disease, also the disease can affect other areas, such as, language, decision-
making ability, judgment, attention, personality and other areas from mental 
function.         
Alzheimer's disease is characterized by two abnormalities in the brain: the amyloid 
plaques and the neurofibrillary tangles. The amyloid plaques are agglomerations 
formed by beta amyloid protein, pieces of degenerated neurons and other cells. 
These plaques are located between of nerve cells. The neurofibrillary tangles are 
knots of twisted filaments which are inside the neurons. These tangles are almost 
entirely composed of a protein which is called tau [3].  
In healthy neurons, the tau protein helps the microtubules functioning (on the left of 
figure 4). These microtubules form the cell's structure and distribute substances 
across the nerve cell. However, in Alzheimer's disease the tau protein is changed. 
This is twisted to form pairs of helical filaments which are grouped to form tangles. 
When this happens, the microtubules cannot function adequately and they 
disintegrate (on the right of figure 4). This failure in the transport system of the 













In the development of Alzheimer’s disease we can observe several stages which 
are characterized by a continuous and progressive deterioration of the brain (on 
the right part of figure 5). 
 
 
Figure 5: Comparing of Normal patient’s brain and Alzheimer's patient's brain (left) and the 
parts of the brain which are affected in the development of Alzheimer's disease (right). 
 
These stages are the following: 
1. Early stage or Phase 1 (at the top-right of figure 5) 
 
This first stage is characterized by some loss of memory which can be mild 
enough but which can interfere in the daily life of the person with the 
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passing of time. Regarding behavior, patients have humor changes and 
even angers. In this stage, they do shorter sentences, mix ideas and have 
problems to find words but they still reason adequately. 
 
2. Intermediate stage or Phase 2 (at the center-right of figure 5) 
 
In this stage the situation worsens. The recent memory decreases and the 
changes in behavior are more pronounced. Patients are more dependent 
than in the previous stage, they need help for self-care. The language is 
also affected and they begin to lose balance and have spontaneous 
downfalls.  
 
3. Advanced stage or Phase 3 (at the bottom-right of figure 5) 
 
In the last stage, patients depend absolutely on third people. They need 
help to do the basic tasks, such as, eating, cleaning, moving, and cooking. 
The recent and remote memory begins to lose. Their behavior is like a little 
child and they babble. They have difficulty to swallow and do not control 
their gestures. 
As we can see, Alzheimer’s disease has a progressive and slow evolution with 
slight problems in the first stage, having severe brain damages in the last stages. 
 
VASCULAR DEMENTIA 
Vascular dementia, after Alzheimer's disease, is the second most common cause 
of dementia [8]. This is a secondary dementia because this is caused by chronic 
reduced blood flow to the brain, usually as the result of a stroke or series of 
strokes. 
 
Figure 6: Comparing of Normal patient’s brain (left) and Vascular dementia patient's brain 
(right). 
 
This type of dementia refers to a subtle progressive decline in memory and 
cognitive functioning. It occurs when the blood supply carrying oxygen and 
nutrients to the brain is interrupted by a blocked or diseased vascular system (on 
the right of figure 6). In many cases, the vascular dementia can coexist with 
Alzheimer’s disease.  
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The incidence to suffer vascular dementia increases in elderly people and it is 
similar in men and women. Currently, there is not known cure, but the use of 
practical strategies may help prevent strokes and slow its development [8]. 
 
FRONTOTEMPORAL DEMENTIA 
The frontotemporal dementia or Pick’s disease, describes a set of diseases 
characterized by a degeneration of nerve cells which are in the frontal and 
temporal lobes of the brain (Figure 7) [9]. 
 
 
Figure 7: The parts of the brain which are affected by Frontotemporal dementia. 
 
The people which suffer this type of dementia often have problems to maintain 
normal interactions with other people because this type of dementia affects the 
frontal and temporal lobes of the brain which control judgment and social behavior.  
 
LEWY BODIES DEMENTIA 
This is the second most common type of progressive dementia after Alzheimer’s 
disease [10]. This type of dementia produces the death of cells which are in the 
cerebral cortex or outer layer, and are also in the black substance, which is located 
in the medium brain. Many of these nerve cells contain some abnormal structures 
which are called, Lewy bodies. These structures are abnormal microscopic protein 
deposits in the brain that disturb the brain's normal functioning causing it to slowly 
deteriorate. The effects include a degradation of cognitive functioning, similar to 








This type of dementia describes a set of dementias which affect the structures 
below the cortex (Figure 8). Among them we can include degenerative diseases of 
basal nuclei, such as, Huntington's disease, Parkinson's disease and Wilson 
disease [12].  
Its disorders are characterized by abnormal movements which are often 
considered as a manifestation of the affection in the basal nuclei (Figure 8). In 
patients who suffer this type of disease, it is more common to see changes in 
personality, slowing down of thought processes and some alterations in memory, 
but language appears largely unaffected [12]. 
 
 










Positron Emission Tomography 
To achieve the aim of this project, that is to say, to analyze the brain metabolism 
degradation in the development of Alzheimer’s disease, we will have to analyze 
images which show the brain metabolism. For this reason, in this chapter we will 
describe the best technique used to obtain this kind of images: The Positron 
Emission Technique (PET). 
So, this chapter is divided in the following way: in the first section, an overview of 
this technique will be shown; and in the second section, the most common 




Positron Emission Tomography (PET) is an imaging technique of nuclear medicine 
which provides information about the metabolism and the functioning of various 
biological systems. This technique is complementary to the morphological 
techniques (computed tomography (CT) or magnetic resonance (MR)) which offer 
a closer anatomical and structural detail [13]. 
Currently, the Positron Emission Tomography (PET) is a very interesting technique 
in the study of the brain metabolism in various diseases, such as, brain tumors, 
epilepsy and dementia. 
The objective of this technique is to mark a biological molecule (tracer), the 
behavior of which it wants to follow, with a radioactive atom (radioisotope). This 
radioisotope is injected into the patient's blood and it goes to areas of the body 
where the tissue is damaged or is not working adequately. In this way, it is 
possible to study different biological processes depending on the tracer used [13]. 
The radiation produced by these radioisotopes will be detected by the system, and 
after computer analysis, a volume of images formed by voxels can be 
reconstructed in a 3-dimensional space. This volume of images will show the tracer 




Figure 9: The process of PET scans generation. 
 
The dose of radioisotopes used in these studies is extremely low, but this dose 
does not cause adverse effects to the patient. However, the cost of these cameras 
is significantly high.  Even so, it is necessary to have a near cyclotron for the 
synthesis of radioisotopes, which have a short life and which disintegrate rapidly. 




The PET technique is focused on these two elements: tracer and radioisotope. The 
tracer or biologic marker is a substance, measure or indicator of a biological state; 
the radioisotope is an isotope which emits radiation when it is combined with the 
tracer. This radiation is captured in the PET camera and this will allow us to obtain 
the corresponding image. Therefore, the tracer allows doctors to study a biological 
process and the radioisotope joins the tracer to follow its process.  
In this way, depending on the used tracer, it is possible to study different biological 
processes. We can see some examples in table 2: 
 
 
Radioisotope         + Tracer               permit the study of 
Oxygen 15 H2O Cerebral Perfusion or 
cerebral blood flow. 
Carbon 11 Flumazenil Cerebral Receptors or 
cerebral tumors 
 




However, the most clinic application of PET technique is the study of metabolism 
[13]. In this case, the most used radioisotope is the Fluorione-18(F-18) and the 




                           .  
 
Figure 10: The structure of Fludeoxyglucose. 
 
The FDG is stored into cell, but in contrast to normal glucose, it cannot be used to 
produce energy, and it is saved into the cell. In this way, the capture of FDG in the 
cells is proportional to their metabolic level. At the same time the FDG is saved in 
the cell, the F-18 radioisotope suffers a nuclear disintegration because this 
radioisotope is unstable. This disintegration provokes the liberation of one positron 
which is discomposed when this combines with a near electron. This also provokes 
the emission of 2 photons which travel in opposite sense (Figure 11). The PET 










The FDG can be used for the assessment of glucose metabolism in heart and 
brain, but also, for image tumors in oncology because these types of tissue have a 
significant higher metabolism (glucose uptake).  
 
So, the main function of PET scans in the diagnos is of Alzheimer’s disease is to 
locate active areas of the brain, and the FDG is used for the assessment of 











Most of the symptoms shown by patients with dementia are symptoms of a 
neuropsychological nature [14]. So, this chapter will show how the 
neuropsychological evaluation has an important role in the identification of 
dementia and also in its diagnosis.  
This evaluation is composed of a set of methods and techniques which allow 
doctors define clinically the state of the patient cognitive abilities. Although the 
psychological tests are considered the best tool to achieve this, this evaluation 
includes more information than the performance of these tests. For this reason, the 
application and interpretation of these tests may be performed by a specialized 
neuropsychologist to achieve certain objectives, such as, early detection, the 
contribution to the diagnosis, affected cognitive abilities and the severity degree 
[15]. 
This is a complex process which main objective is the interpretation of many data 
and the conclusion of a possible diagnosis. This diagnosis will be then 
corroborated with the remaining pieces of the evaluation. 
In the patients evaluation several tests combinations will be used. These 
combinations must: 
- Be sensitive to different types of cognitive impairment. 
- Allow to use them in elderly people. 
- Be standardized or have control group scores. 
- Have clinic efficiency which has been checked in the classification of 
several patients with different types of dementia. 
- Allow to evaluate more than one cognitive ability. 
 
Then, the characteristics of these tests are explained. 
 
4.1  Initial Evaluation 
To start the neuropsychological evaluation it is usually used short tests which are 






Mini Mental State Examination (MMSE) 
This is a short cognitive test which has the greatest validity and international 
diffusion. This is usually used with other scales, such as, the FAST scale which it 
will see in table 3. This kind of test is performed in 5 or 10 minutes and it evaluates 
the orientation, the registration of information, the attention and calculation, 
memory, language and construction [16]. 
Its maximum score is 30 and its cut-off point is 26 [16]. A result below of this value 
suggests a cognitive impairment, but a normal result does not allow doctors to 
discard some eventual impairment. 




Figure 12: Some questions of MMSE Test. 
 
Though this test is helpful to do an initial examination of cognitive disorders, it 
must not be used to do a complete neuropsychological examination because it has 
problems to detect different degrees of severity and it does not evaluate any 
cognitive abilities. 
 
Clock Drawing Test (CLOCK Test) 
This is a screening test to assess the patient cognitive state in the earlier states 
and for the early diagnosis. In this test the patient have to: 
- Draw a clock.  
- Draw a sphere,  
- Put all hours on the sphere 
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- Put the hands at 11:10. 
 
In this way, to evaluate the cognitive state of patient, the scoring criterion is the 
following [17]: 
 
1.  Sphere (2 points): 
 
a. Normal picture (2 points) 
b. Incomplete (1 point) 
c. Completely distorted picture (0 points) 
 
2. Numbers sequence (4 points): 
 
a. All numbers and correct order (4 points) 
b. Error in 4 or more numbers (3.5 points) 
c. All numbers but bad located (3 points) 
d. Error in the placement of numbers or incorrect alignment (2 
points) 
e. Lack or excess of numbers, poor positioning and alignment (1 
point) 
f. Low representation of numbers (0 points) 
 
3. Presence and location of the hands (4 points) 
 
a. Right position and adequate size (4 points) 
b. Right position and equal size (3.5 points) 
c. Errors in the placement and size is not correct (3 points) 
d. Severe distortion in the placement of the hands or not fit in the 
central area. (2 points) 
e. Error in the placement of the hands they do not join in the central 
position (1 point) 
f. No hands. (0 points) 
 
In this test, the cut-off point is 6. Therefore, the test is considered positive if the 
final score is lower than 6, and the test is considered negative if the final score is 
bigger than 6. The highest scores are used to discard the disease, especially the 
scores near to 8 and 9 [17]. 
This test provides useful information about various cognitive areas which are 
activated when the patient does this short task. These areas are similar to those 
evaluated in MMSE test, that is to say, language, short-term memory and 
executive functions. Moreover, the Clock Drawing Test is highly sensitive and 
specific [17]. 
The next scales can be also helpful to do an initial evaluation:  
- Global Deterioration Scale (GDS) 
 
- Functional Assessment tool for Alzheimer´s Disease (FAST) which we 









This type of test is frequently used in the initial evaluation. The aim of this test is to 
identify whether the patients with cognitive disorders have a high genetic risk to 
develop Alzheimer’s disease [18]. The result of this test constitutes one more data 
about the patient which is registered with all the demographic information of the 
patient. In order to do this test the only requirement is to do a blood test to the 
patient and analyze this blood sample by techniques PCR (Polymerase Chain 
Reaction) [18]. These techniques allow the amplification of the DNA fragment [19], 
which can be visualized by the specialists in order to analyze the ApoE gene, since 
this gene is considerate a susceptibility genetic factor to develop Alzheimer’s 
disease. 
 
4.2  Global Evaluation 
 
Alzheimer Disease Assessment Scale (A.D.A.S) 
To do global evaluations about dementia, such as, Alzheimer’s disease, this is the 
most used scale. This has an easy and fast administration even in advanced 
stages of dementia. This scale mainly evaluates language, memory and apraxia. 
This type of test is performed in 30 or 60 minutes depending on the disease’s 
phase [20]. 
This scale asses the cognitive state and the behavior of patients who suffer 
Alzheimer’s disease. Its maximum score is 120 points. The highest values 
correspond to patients who have more impairment [20]. 
The scale is divided in 11 items which evaluate the cognitive abilities, such as, 
memory, language, apraxia and orientation; and in 10 items which evaluate the no 
cognitive abilities, such as, mood and behavior. This evaluation indicates the 
memory and language items as impairment signs, although apraxia, order 
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execution and denomination are the most frequently modified. Nevertheless, the 
orientation item is the one which best shows the disease progress [20]. 
 
Consortium to Establish a Registry for Alzheimer’s disease (CERAD) 
The Consortium to Establish a Registry for Alzheimer’s disease (CERAD) was 
established in 1986 by a grant from the National Institute on Aging (NIA), to 
standardize procedures for the evaluation and diagnosis of pat ients with 
Alzheimer’s disease (AD) [21].  
CERAD developed the following standardized instruments to assess the various 
manifestations of Alzheimer’s disease: 
- Clinical/Neuropsychology 
- Neuropathology 
- Behavior Rating Scale for Dementia 
- Family History Interviews 
- Assessment of Service Needs 
 
The above neuropathology criteria are widely used in the US and other countries 
for the studies of Alzheimer’s disease and other dementias of elderly people.  
 
The CERAD Behavior Rating Scale for Dementia (BRSD) is a standardized 
instrument for rating behavioral abnormalities in demented or cognitively impaired 
subjects. Descriptive items are scaled according to frequency of 
psychopathological behavior. 
For more information about CERAD, please visit the official CERAD website: 
http://cerad.mc.duke.edu. 
 
Clinical Dementia Rating Scale (CDR) 
This test was developed at Washington University School of Medicine in 1979. 
Primarily this was developed for diagnosing dementia of the Alzheimer’s type, but 
then this can also be used to evaluate other types of dementia. CDR scores the 
person’s cognitive ability. It is a five-point scale. CDR=0 connotes that people have 
no cognitive impairment, and the remaining four points are for various stages of 
dementia [22]: 
 CDR = 0: no impairment 
 CDR = 0.5: questionable dementia 
 CDR = 1: mild dementia 
 CDR = 2: moderate dementia 
 CDR = 3: severe dementia 
 
The CDR will be tested by an interview with the patients. The CDR score is based 
on 6 domains: memory, home and hobbies, orientation, judgment, community 
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In this chapter, all the necessary information about the PET scans which have 
been used in this project will be developed. Also, all the steps which have been 
followed to analyze the PET scans will be explained. 
 So, this chapter has been organized from the acquisition of the images (PET 
scans) until its disposition to use them in the creation of the ordering graph. 
 
5.1  Acquisition 
Given that, this study is focused on analyzing how the brain metabolism 
degradation evolves in Alzheimer’s disease, it is necessary to use some type of 
image which allows us to examine the brain metabolism.  
Among the medical image techniques that better visualize this type of activity, the 
functional techniques are highlighted, specifically, the nuclear medicine 
techniques, that is to say, the PET technique (Positron Emission Tomography) and 
SPECT technique (Single Photon Emission Computed Tomography). Between 
them, the PET technique has a greater spatial resolution than SPECT technique. 
Therefore, the PET technique is the best showing the brain metabolism for 
different pathologies, such as, dementia. For this reason, we use images which 
have been obtained by this technique. 
So, in order to do this project the images are taken from this website: Alzheimer’s 
disease Neuroimaging Initiative (ADNI; http://adni.loni.ucla.edu/). This is an open-
source page which goal is to define the Alzheimer’s disease progression. In this 
site, data from Alzheimer’s disease patients, mild cognitive impairment subjects 
and elderly controls are available to download.  
The obtained images are ‘co-registered, average’ [23] and are classified in three 
folders: Normal Control (NC), Mild Cognitive Impairment (MCI) and Alzheimer’s 
disease (AD). The NC folder has the PET scans from people who do not have any 
cognitive disorder, in other words, healthy people. The MCI folder has the PET 
scans from mild cognitive impairment subjects, and the AD folder has the PET 
scans from Alzheimer’s disease patients. 
For the analysis and obtention of the corresponding graph, we use 30 PET images 
with Normal Control, 52 PET images with Mild Cognitive Impairment and 25 PET 
images with Alzheimer’s disease. 
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The images with mild cognitive impairment (MCI) and Alzheimer’s disease (AD) are 
put in the same folder which is called “Disease_images”; and the images with 
normal control (NC), are in another folder, called “Healthy_images”. 
 
5.2  Pre-processing 
Once we have the PET scans, a preprocessing of these PET scans are performed. 
This preprocessing is necessary to use and analyze the PET scans in the correct 
form. So to carry out this preprocessing, the next programs: MATLAB, SPM5 and 
XMedCon are used. 
MATLAB is a numerical computing environment as well as a programming 
language developed by The MathWorks, Inc [24]. It allows the user to do a lot of 
things with the data, but in this project, this program is only used to run SPM5. 
SPM5 is an update version of SPM (Statistical Parametric Mapping) [25]. SPM is 
software to construct and evaluate spatially extended statistical processes. SPM is 
based on MATLAB so it can only run under MATLAB. By using SMP, brain imaging 
data can be analyzed. For this reason, SPM5 is used to normalize and smooth the 
PET scans which are used in this project. 
The Medical Conversion (MedCon) is an open-source tool which aim is the 
conversion of medical images. This program is released under the GNU’s (L) GLP 
license, and supports a lot of formats.  Its main purpose is image conversion and 
particularly to reconstruct nuclear medicine images [26]. Even though, this program 
can be used to do a lot of things, in this project, it is only used to get the images 
conversion. 
Once all the programs used to perform this preprocessing have been mentioned, 
we show a schematic view about all the steps which are followed to achieve this 
preprocessing:  
1. To normalize each PET scan, we apply: 
 
a. Spatial normalization by using SPM5 [25] 
b. Smoothing use a kernel size [8 8 8] mm [25] 
c. intensity normalization by 'Grand Mean': 
 
i.  that was done by dividing each voxel's intensity value by 
(1+1/8)*mu(image), that is: 
 
Voxel (processed) = voxel (original) / ((1+1/8) * mu (image)) 
 
o mu (image) is the mean intensity value of the original    
image.     
 
o The reason why (1+1/8) is multiplied because the brain 
image has certain amount of non-brain voxels that are 
near 0 (black), thus it is compensated by increasing '1/8' of 




2. For each normalized PET scans we do: 
 
a. Conversion to ASCII format 
 
So, the first step of this preprocessing consists of three steps: spatial 
normalization, smoothing and intensity normalization. These steps are detailed 
below and are applied to each one of the images which are stored in the folders 
“Disease_images” and “Healthy_images”. 
Firstly, we apply spatial normalization to each image of each folder. This 
normalization is performed because people have different brains in size and 
shape. For this reason, the aim of this normalization is to apply a deformation to 
brain scans to correspond all the brains of the images with the same space or 
dimension. 
Secondly, once we have applied spatial normalization, we apply smoothing. This 
smoothing is applied to each image of each folder after that images have been 
spatially normalized. This smoothing is performed because all data acquires 
certain noise when they are obtained by detection systems, then this noise is 
reflected in the image.  These images can have more or less noise according to 
the conditions in which images are obtained. For this reason, it is recommendable 
to apply some smoothing technique to delete or attenuate this noise among 
images. 
Finally, once the previous steps have been applied, the last step is to apply 
intensity normalization. This normalization is also applied to all images of all 
folders, after that all images have been spatially normalized and smoothed. This 
normalization is done because in this type of techniques, the injected dose can be 
different each time an image of the patient’s brain is obtained. This can lead that 
not all images have the same intensity in each voxel, and therefore, the goal of this 
last step is to establish the same intensity in all voxels of all images. 
Once all the PET scans have been normalized, the files of PET scans have a new 
format, and therefore, the next step is to convert these files to another format 
which will allow us to know the features of the matrices for each PET scan 
normalized. This conversion is done by using the MedCon program. This program 
generates the files of PET scans in format ASCII.  
In this way, each file contains the matrix of each PET scan where the pixel values 
are saved. These values represent the brightness of the pixels. 
Next, we see the MedCon command which has been used to extract a voxel 
intensity matrix from the files of PET scans after the normalization [26]: 
 
medcon –c format conversion –f folder where the original files are –o folder 





As we can observe, the program requires three parameters. In the first parameter, 
we indicate by –c the format it wants to convert the images; as a second 
parameter, we indicate by –f the path of folders where the images are and which it 
wants to convert. In our case, this is the path where the folders “Disease_images” 
and “Healthy_images” are. Finally, as a third parameter, we indicate by –o the path 
of folders, where the convert images have to be saved.  
Given that, the final files of PET scans have a different format from the original, it 
is necessary to create new folders to save these new files of PET scans.  
So, we create the following folders:  
- Disease_imgs_convert 
- Healthy_imgs_convert.  
These folders store the ASCII files of the PET scans which are in the folders 
Disease_images and Healthy_images. So, in our case, the third parameter of the 
MedCon command is the path where the folders “Disease_imgs_convert” and 
“Healthy_imgs_convert” are.  
 
5.3  Utilization 
From the files of PET scans which are contained in the folders: 
Disease_imgs_convert and Healthy_imgs_convert, we know the features of the 
matrices that describe the PET scans. Moreover, the values of these matrices 
represent the pixels values, that is to say, the brain metabolism intensities  of the 
PET scans. 
In this way, analyzing the ASCII files of PET scans, it can be observed that each 
PET scan is composed by 68 slices. These slices make up the PET scan of the 
whole brain. Furthermore, from each file of PET scan we have extracted that a 
PET scan has 68*95*79 voxels, and each slice has 95*79 voxels. 
In this project, we can work with one slice or with all the slices of the PET scan. 
So, if we do the analysis of PET scans by using one slice of PET scans, the 
matrices of PET scans will have 95 rows and 79 columns; otherwise, if we do the 
analysis of PET scans by using all the slices of the PET scans, then the matrices 
of PET scans will have 68*95 rows and 79 columns. In short, in this project we will 
use the values of table 5 according to the study of the PET scans that we want to 
perform: 
 
MATRIX ROWS COLUMNS 
 




















Ordering and Visualization 
This chapter will describe the most important part of this work: the ordering of PET 
scans and its visualization. That is why it has been divided in three points; in the 
first one, an overview of the ordering procedure which has been used to get the 
order of PET scans will be given; in the second point, all this ordering procedure 
will be detailed; and, in the third point, it will be shown the ordering visualization 
regarding graph, and also, regarding node. 
 
6.1  Overview of the procedure 
The objective of this project is to obtain an ordering among PET scans. This 
ordering may visualize the brain metabolism degradation in the development of 
Alzheimer’s disease. Therefore, the objective of this project is to obtain an ordering 
as the one visualized in the following figure: 
 
 
Figure 13: Goal of the ordering 
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As we can observe in figure 13, the right arc represents the brain metabolism 
degradation in the development of Alzheimer’s disease; and,  the left arc of the 
figure represents the brain metabolism degradation when the mild cognitive 
impairment appears. 
So, to visualize the brain metabolism degradation, the areas of the PET scans that 
show certain impairment in the brain metabolism, have to be analyzed. To achieve 
this analysis, the matrices associated to the PET scans have been used. 
In this way, to analyze these matrices and to establish the order among PET 
scans, a procedure is followed. This procedure consists of the following steps: 
1) Convert the files of PET scans to ASCII format. 
 
2) Create a healthy control matrix. This matrix will contain the minimum values 
of the brain metabolism and will serve as a baseline to calculate the disease 
status of the PET images. The matrix obtained in this step will be the 
minimum healthy matrix.  
 
3) Obtain the matrices that will contain the difference between the matrix 
calculated in step 2, and the matrices associated to the PET scans. The 
matrices obtained in this step will be the difference matrices.  
 
4) Compare the difference matrices calculated in step 3, using the next 
variables: 
 
a. Variable 1: this variable will store the amount of elements of the 
difference matrix, which will indicate the affected areas of the PET 
scan. This variable will be called nvot. 
b. Variable 2:  this variable will store the amount of elements that the 
difference matrices will have in common. Therefore, this variable will 
indicate the affected areas which the PET scans will have in 
common. This variable will be called nvotaiop. 
c. Variable 3: this variable will store the percentage of overlap area that 
the difference matrix will have. Therefore, this variable will indicate 
the percentage of affected area that the PET scan will have. This 
variable will be called content_ratio. 
 
5) Establish the order among PET scans, using the difference matrices 
calculated in step 3, and the following parameters: 
 
a. Parameter 1: this parameter will be used to calculate the variable 
nvot. This parameter will be called param_1. 
b. Parameter 2: this parameter will be used to select the difference 
matrix with a greater overlap area. This parameter will be called 
param_2. 
c. Parameter 3: this parameter will be used to compare the overlap 
areas of the difference matrices and establish the order among PET 
scans. This parameter will be called param_3. 
So, the procedure that it has been used to obtain the order among PET scans and 
the visualization of the brain metabolism degradation in the development of 
Alzheimer’s disease has been defined.  
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In point 6.2, all the calculations performed in each one of the previous steps will be 
detailed. 
 
6.2  Description procedure  
This point describes in more detail the procedure which was explained in the point 
6.1. Therefore, the parts that make up this point are: the Input, Processing and 
Output of the procedure.  
To better understand what it will be done in each part everything is shown in the 
following schematic view: 
INPUT 
1. Convert the files of PET scans to ASCII format. 








4. Connectivity matrix definition. 
 
PROCESSING 
1. The obtaining of the minimum healthy matrix. 
2. The obtaining of the difference matrices. 
a. Difference matrices comparison: 
i. Calculate the variable nvot for each difference matrix 
ii. Calculate the variable nvotaiop 
iii. Calculate the variable content_ratio for each difference 
matrix. 
3. The ordering of the PET scans: 













In this part all the elements which have been used to carry out all the ordering 
procedure are detailed. 
The main component of this procedure is the PET scans that want to be ordered. 
To analyze these PET scans, it is essential to know the matrices associated to 
these PET scans. For this reason, the first step was the conversion of the files of 
the PET scans to ASCII format. This step was explained in chapter 5, and the 




In this way, the files of PET scans in ASCII format have been obtained and the 
features of the matrices associated to the PET scans are known. The matrices 
associated to these PET scans have the features shown in the table 5 of chapter 5. 
The second step of this procedure is to obtain the matrix that will store the 
minimum values of the brain metabolism. For this reason, it has to be defined one 
matrix to save these values. This matrix is called: minimum_healthy_matrix and it 
is an input of this procedure. 
The third step of this procedure is to obtain the difference matrices. The values of 
these difference matrices are stored in files. Given that the PET scans are formed 
by slices, we can obtain the ordering of PET scans by analyzing one slice or 
analyzing all the slices of PET scans. Therefore, the calculation of the difference 
matrices also depends on the type of study that we do. So, these two studies imply 
the definition of two folders to save the files with the values of the difference 
matrices according to the study that we do. 
Given that in this study it is used the slice 32 of PET scans, because it is the slice 
which better shows all the areas in the brain. Therefore the difference matrices are 
stored in the following folders: 
- Difference_imgs_32: this folder stores the difference matrices when one 
slice of PET scans is used. 
 
- Difference_imgs_all: this folder stores the difference matrices when all the 
slices of PET scans are analyzed. 
 
Once all the folders have been explained, the variables and parameters which will 
be used to compare the difference matrices and to get the order among PET scans 
will be defined. This is, the variables: nvot, nvotaiop, content_ratio; and the 
parameters: param_1, param_2 and param_3. 
Once all the folders have been created, and the variables and parameters which 
are needed have been defined, it only remains to define the output of all 
procedure, this is: the ordering graph. This is represented as a connectivity matrix. 
This connectivity matrix will store all the connections of the ordering graph. This 
matrix is called graph1 and its size will be defined according to the analysis that 
will be done. So, analyzing the table 5 of chapter 5, the size of graph1 will be 95 
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rows and 79 columns, if we analyze one slice of the PET scans; otherwise, the size 
of graph1 will be 6.528 rows and 79 columns, if we analyze all the slices of the 
PET scans. 
In this way, all the elements that have been needed to perform this procedure have 
been detailed. So, in point 6.2.2 the processing part is explained. 
 
6.2.2 Processing 
In this part all the calculations to get the ordering among PET scans are detailed.  
First of all, it is necessary to know which areas of the PET scans are affected by 
disease, that is to say, which areas of the PET scans have certain impairment in 
the brain metabolism. For this reason, the first step of this procedure is to relate 
the healthy and diseased images. 
Analyzing the PET scans of healthy people, it can be observed that not all brains 
will have the same shape and active areas. So, it depends on some factors, such 
as, the age, education and sex of the person. Therefore, to extract correctly the 
affected areas of the PET scans of diseased people the whole set of PET scans of 
healthy people is used. 
So, to know which areas of PET scans of diseased people have impairment in the 
brain metabolism, it should be known which the minimum brain metabolism is 
observed in the healthy people. For this reason, the first step of this procedure is 
to calculate a matrix which will contain the minimum values of the brain metabolism 
in healthy people. 
 
6.2.2.1 The obtaining of the minimum healthy matrix 
 
The size of this matrix also depends on the study which wants to be carried out. 
So, analyzing the table 5 of chapter 5, the size of this matrix will be 95 rows and 79 
columns, if we analyze one slice of the PET scans; otherwise, the size of this 
matrix will be 6.528 rows and 79 columns, if we analyze all the slices of the PET 
scans.  
 
Therefore, this matrix is obtained in the following way: 
 
For each voxel in healthy image  
   If (healthy_image [ ] [ ] < min)  
            minimum_healthy_matrix [ ] [ ] = value1; 
 
 
Once the minimum healthy matrix has been calculated, the next step is the 








6.2.2.2 The obtaining of the difference matrices 
 
These matrices will contain the difference between the minimum healthy matrix 
and the matrices associated to the PET scans of diseased people. In this way, the 




For each element in minimum healthy matrix 
  For each element in disease matrix 
    difference_matrix [ ] [ ] = minimum_healthy_matrix [ ] [ ] – disease_matrix [ ] [ ]; 
 
 
From this calculation, the difference matrices have the values that help to detect 
which areas of the PET scans of diseased people have certain impairment in the 
brain metabolism. Therefore to know these areas, the values of these difference 
matrices are analyzed.  
So, the difference matrices have positive and negative values. The positive values 
determine that the minimum metabolism is higher than the metabolism in the PET 
scan of the diseased person. In the other case, the negative values determine that 
the minimum metabolism is lower than the metabolism in the PET scan of the 
diseased person.  
Given that we want to analyze which areas of the PET scans of the diseased 
people have certain impairment in the brain metabolism, we select the values of 
the difference matrices which indicate this impairment in the brain metabolism.  
So, these values are the positive values of the difference matrices because they 
represent that the brain metabolism in the PET scans of the diseased people is 
lower than the minimum brain metabolism which has been observed in the PET 
scans of the healthy people, and therefore, they represent the areas of the PET 
scans of diseased people that have some impairment in the brain metabolism.  














As it can be observed, the colored values are the positive values. These values 
indicate that, the values of the minimum healthy matrix are higher than the values 
of the matrix associated to the PET scan of the diseased person.  Given that the 
values of these matrices are the values of the brain metabolism, it can be confirm 
that the positive values of the difference matrix indicate that, in the PET scan of 
the diseased person there is certain impairment in the brain metabolism because 
this metabolism is lower than the minimum metabolism observed in the PET scans 
of healthy people.  
Once it has been understood the reason by which the positive values have been 
selected in the difference matrices, the next step is: The comparison of the 
difference matrices.  
 
6.2.2.3 The Comparison of the difference matrices 
 
In this step, the difference matrices are compared to know how much affected area 
has each one. This knowledge about the affected areas in the PET scans allows us 
to obtain the order among PET scans. 
 
So, to compare the difference matrices and to get the order among the PET scans, 
some calculations using the difference matrices are done. So, in the following 
points (6.2.2.3.1, 6.2.2.3.2 and 6.2.2.3.3) all these calculations are explained.  
 
6.2.2.3.1  The calculation of the nvot variable. 
The first calculation is to calculate the amount of elements of the difference 
matrices that indicate areas with certain impairment in the brain metabolism of the 
PET scans of the diseased people. The elements of the difference matrices that 
indicate this impairment in the brain metabolism, are the positive values (see point 
6.2.2.2). Given that the parameter 1 has to select these elements in the difference 









As we have seen in the point 6.1, this calculation corresponds with the variable 1 
called, nvot. This variable is calculated for all difference matrices in the following 
way: 
 
For each voxel in difference image 
If (difference_matrix [ ] [ ] >= param_1) 
           Count ++; 
 
 
6.2.2.3.2 The calculation of the nvotaiop variable. 
The second calculation is to calculate the amount of elements that the difference 
matrices have in common. The values of this variable indicate the affected areas 
that the PET scans of diseased people have in common. 
As it can be seen in the point 6.1, this calculation corresponds with the variable 2 
called, nvotaiop. This variable is calculated in the following way: 
 
For each voxel in difference_matrix1 and difference_matrix2 
      If (difference_matrix1 [  ] [  ] >= param_1 &&  
           difference_matrix2 [  ] [  ] >= param_1)   
                  Count++;  
   
 
 
6.2.2.3.3 The calculation of the content_ ratio variable 
The third calculation is to calculate the percentage of the overlap area that the 
difference matrices have. These percentages indicate the overlap area that the 
PET scans of diseased people have. 
As it can be seen in the point 6.1, this calculation corresponds with the variable 3 
called, content_ratio. This variable is calculated in the following way: 
 
content_ratio = (nvotaiop /nvot) * 100; 
 
 
In this way, all the necessary calculations to order the PET scans of the diseased 






6.2.2.4 The Ordering of PET scans. 
 
To obtain the ordering among PET scans of the diseased people, the difference 
matrices are compared by using the values of the content_ratios and the 
parameters 2 and 3. Then, the parameters evaluation is explained. 
 
6.2.2.4.1 Parameters Evaluation 
The first step to get the ordering among PET scans of the diseased people is to 
calculate the maximum content_ratio of the two difference matrices which are 
compared. This maximum determines which difference matrix has more overlap 
area. 
When the maximum content_ratio have been calculated, the second step is to 
evaluate this maximum content_ratio with parameter 2. So, this parameter 
determine if the PET scan associated to the difference matrix with a maximum 
content_ratio, should be anterior than the other PET scan associated to the other 
difference matrix which is compared. However, the position of one PET scan 
cannot be confirmed until performing the evaluation with parameter 3. 
In order to do this comparison, first the difference among the values of 
content_ratios is performed. This difference indicates if the overlap areas of 
difference matrices are similar or not. 
Once the calculation of the difference among the values of the corresponding 
content_ratios has been done, the next step is to compare this difference with 
parameter 3. This parameter determines if this difference is enough high to put the 
PET scans one before the other, or if this difference is low and the PET scans 
should be in the same level in the ordering graph. 
All the before procedure is done for all difference matrices which have been 




Max = we calculate the maximum value of the content_ratios; 
If (max >= param_2) 
 To obtain the difference among the content_ratios; 
 If (difference >= param_3) 
  The images are progression; 
  Grafo1 [ ] [ ] = 1; 
 Else   
  The images aren’t progression; 
  Grafo1 [ ] [ ] = 0; 
 
 
In this way, the order among PET scans of the diseased people is got, and the 






Finally, an example is developed to better understand all the before comparison 
and all the ordering procedure. First of all, two difference matrices are defined to 
do all the calculations. These difference matrices are the following: 
 
                 Difference_img1                                Difference_img2 
 
As a first step, we select the positive values of the difference matrices. To do that, 
we need to compare all the values of the difference matrices with the parameter 1 
which value is 0, and we select all the values over of this parameter. As we can 
see above, these values are the colored ones. 
Once we have selected the positive values, we calculate the variable nvot, that is 
to say, the amount of positive values that are in each difference matrix. So, for the 
difference matrix 1 we have nvot1 = 5, and for the difference matrix 2 we have 
nvot2 = 7. 
Now, the next step is to calculate the variable nvotaiop, that is to say, the amount 
of positive values that are in the same position in both difference matrices. Then, 
we see how we have to do it: 
 
                  Difference_img1                             Difference_img2 




As we can see, the rounded values are in the same position in both matrices, and 
therefore, the value of the nvotaiop variable is 4 because there are 4 positive 
values in the same position in both matrices. So, this variable establishes the area 
that both difference matrices have in common, and therefore, the affected area 
which the associated PET scans have in common. 
When all these values have been calculated, the last step is to calculate the values 
of the content_ratio variable for each difference matrix. These values are a 
percentage which describes how much overlap area there is in each difference 
matrix.  
For our difference matrices, we have: 
Difference matrix 1  CR1 = (nvot1 / nvotaiop) * 100 = (4/5) * 100 = 80% 
Difference matrix 2  CR2 = (nvot2 / nvotaiop) * 100 = (4/7) * 100 = 57% 





























Table 6: Results of the calculations in the example. 
 
As we can see in table 6, PET scan 1 associated to difference matrix 1, has more 
overlap area than PET scan 2 associated to difference matrix 2. So, that means 
that, PET scan 1 has a lower affected area than PET scan 2, and therefore, the 
brain metabolism degradation is more appreciated in PET scan 2. For this reason, 
we could put PET scan 2 after PET scan 1, but to confirm this order, we have to 
continue with the procedure. So, the next step is the parameters evaluation. 
The first step to do the evaluation of the parameters is to calculate the maximum 
content_ratio. In this example, observing table 6 we know that the maximum 
content_ratio is the content_ratio of PET scan 1 associated to difference matrix 1. 
So, this value is 80%. 
The second step in this part of the procedure is to compare this maximum 
content_ratio with parameter 2. So, if we suppose a value for parameter 2 = 50%, 
the comparison is true because 80 is bigger than 50. Therefore, we compare the 




In this way, the last step of this part is to calculate the difference between the 
values of the content_ratios associated to the difference matrices which we are 
comparing. So, we make this difference as we can see below:  
 
 
Difference = max (content_ratio) – content_ratio =  
 
= content_ratio 1 – content_ratio 2 = 80% - 57% = 23% 
 
 
Finally, we compare this difference with parameter 3. So, if we suppose a value for 
parameter 3 = 10%, the comparison is also true because 23% is bigger than 10%. 
Therefore, we can establish the order between the PET scans associated to the 
difference matrices which we are comparing. Therefore, and as we can observe in 
this example, PET scan 1 should be anterior to PET scan 2.  
So, these are all the steps which have been followed to get the order.  
 
Although in this example the connection between the PET scans is possible, it 
could appear the case in which the connection would not be possible. Therefore, 
the connections will depend on the values in the parameters 2 and 3. These 
parameters are the most important to get a correct order, so, good values will have 
to be chosen. These values will be discussed in chapter 7, where several orderings 
will be shown in different examples and which will help to conclude which values 
are the best for these parameters. 
 
6.2.3 Output 
The output of this procedure is the connectivity matrix, graph1. In this graph all the 
connections among nodes are stored, and therefore, this is the matrix which 
determines the order among PET scans of the diseased people. 
In point 6.3, the visualization of this graph is explained, as well as, the visualization 
regarding node. In this visualization additional information about PET scans is 
displayed. This information will be helpful to better understand the connections in 
the graph. 
 
6.3  Application Description 
To visualize the order of PET scans a java application has been implemented 
using the tool Netbeans: an integrated development environment (IDE) [27]. 
Nowadays, this is considered the most popular IDEs in the development of Java 
applications. That is why we have used this tool to implement our application. It is 
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free to download and easy to install. Furthermore, there are plenty of help 
documents on the internet, which make its use easier. 
This application will show the ordering of PET scans using a directed acyclic graph 
(DAG) which can move around the screen, as well as, change its size. 
Furthermore, this application will allow the user to move the nodes and visualize 
additional information for each node clicking the corresponding node. 
The next points (6.3.1 and 6.3.2) show the information which is obtained by using 
the graph visualization, and complementary information is offered in the node 
visualization. 
 
6.3.1 Graph Visualization 
In this part, the connectivity matrix, graph1, is visualized. This matrix has been 
obtained using the procedure developed in point 6.1. So, the visualization of this 
graph allows the user to observe which connections have been established and 
which nodes have connected them. These connections determine the order of PET 
scans, as each node represents each analyzed PET scan. 
In the graph, the connections depend on the level used to do the study of PET 
scans. So, if the study is done at slice level, the visualized graph will offer some 
connections that can change if the study is done at whole brain level.  
Therefore, this application may know which level is used in the analysis of PET 
scans to obtain the order among them. So, the window of figure 14 is offered by 
this application to indicate the level of the analysis:  
 
Figure 14: Window application to select the study level. 
 
Once the level of the study has been indicated, the application displays the graph 
which corresponds to the connectivity matrix, graph1. This matrix stores the 
connections among PET scans and has been created previously. 




Figure 15: Graph visualization. 
 
As the visualized graph is a directed an acyclic graph, the connections, which are 
represented by the edges, will only have one direction and do not produce cycles. 
As it can be seen in figure 15, the nodes are labeled with the number of PET scan 
which each node represents; and the edges are labeled with the names of the 
nodes which each edge connects. This label has in the first position the name of 
origin node and in the second position the name of the destination node.  
The graph visualization allows the user to observe the number of nodes, that is to 
say, the number of diseased images which are analyzed; as well as, the number of 
connections which are established among these images. 
In this example, the graph of figure 15 has 6 nodes, that is to say, 6 diseased 
images have been analyzed and 13 connections have been established among 










































Table 7: Connections in the graph. 
 
As it can be observed in table 7, we can find nodes without connections, such as, 
the node_4 and node_5. The reason could be that these nodes correspond with 
PET scans which have severe brain metabolism degradation, and therefore, the 
ordering procedure has considered them as leaves in the ordering graph. 
Otherwise, it could be because the parameters 2 and 3 have high values which can 
produce that some nodes do not connect with other nodes. For this reason, it is 
important that the parameters 2 and 3 have appropriate values since, the more 
approximated these values are the better order of PET scans will be obtained.  
So, it is important to know the number of connections in the graph because this will 
help in the analysis of the values of the parameters 2 and 3. In this way, depending 
on the values of these parameters, it will have more or less connections in the 
ordering graph. 
Point 6.3.2 shows the node visualization. This visualization offers more information 
about nodes and help to better understand the connections among them.  
 
6.3.2 Node Visualization 
In this point, all the additional information which can be visualized for each node of 
the ordering graph is explained 
The application visualizes this information when the corresponding node is clicked 
twice. Before that, the application shows the window of figure 16. In this window, 




Figure 16: Window application to select the information. 
 




With this option, the application visualizes the Excel file which contains the values 
of difference matrix corresponding to the PET scan that the selected node 
represents. 
The difference matrices can have positive and negative values. So, the positive 
values represent the parts of the brain which show certain degradation in the brain 
metabolism. Given that these parts are the ones which we want to analyze, the tool 
Microsoft Excel has been used to select them. 
The positive values are in a range from 0 to a maximum value so this range is 
selected in a red color. In addition, a degradation of the red color is shown from the 
maximum value to the values near 0. In this way, the affected areas of the PET 
scans corresponding to the difference matrices are selected. 





Figure 17: Difference matrix visualization. 
 
As it can be appreciated in figure 17, this image offers the zones of PET scans 
which have certain brain metabolism degradation.  
The values of difference matrices are the differences between the values of 
minimum healthy matrix and the values of diseased matrix. So, a high value in the 
difference matrix means that, the value of the diseased matrix is smaller than the 
value of the minimum healthy matrix, and therefore, the difference among them is 
higher. In this way, this high value indicates that in the diseased image the 
metabolism is lower than the minimum metabolism, and therefore, it is an area with 
a greater impairment in the brain metabolism. In this case, this area is more 
affected by illness. For this reason, the areas with high values are colored with an 
intensive red. 
On the other hand, the areas with a less intense red represent a lower impairment 
in the brain metabolism, and therefore, zones less affected by illness. However, 
these areas could be zones that the illness is beginning to affect. So, the obtaining 
of these images for each difference matrix provides a greater knowledge about the 
areas affected by the illness. In addition, the visualization of these images will help 
to better understand the position of the PET scans in the ordering graph. 
 
PET scans 
With this option, the application visualizes the PET scan corresponding to the 
clicked node. Moreover, the application allows the user to execute two programs of 
medical image processing. These programs will offer the user more information 
about the visualized PET scan, but also, other functionalities that will help to 
analyze the PET scans. 





Figure 18: PET scan visualization. 
 
As it can be appreciated in figure 18, the programs XMedCon and MRIcroN can be 
executed to better analyze the visualized PET scan. So, these programs can be 
executed using the buttons which are located at the bottom part of the image.  
In this way, using the left button the user can run the XMedCon program. This 
program is usually used to converse medical images, but it also offers a graphical 
user interface in which all the slices of PET scans can be visualized.  So, running 




Figure 19: The user interface of XMedCon. 
 
In figure 19, it can be appreciated that this program offers a lot of options to 
analyze the medical images (at the top-left of figure 19). However, in this project 
this program has been only used to convert the image and visualize the slices of 
PET scans. Therefore, this program has been added in the node visualization 
because, in a future work, all the functionalities of this program could be used to 
analyze in depth the PET scans. 
On the other hand, using the right button the user can run the MRIcroN program. 
This is another of the most used software in medical image processing. MRIcroN 
offers a graphical user interface which allows the user to visualize the PET scans 






Figure 20: The user interface of MRICroN. 
 
This program is usually used to locate regions of interests (ROIs, e.g. tumors). 
However, in this project this program has been only used to obtain the axial view of 
the slice 32 of the PET scans, and to get the PET scans with the colors that can be 
appreciated above. Nevertheless, this program offers lots of options to analyze the 
medical images. Therefore, this program has been added in the node visualization, 
because in a future work all the functionalities of this program could be used to 
analyze in depth the PET scans or to locate the ROIs of these PET scans.  
 
Difference matrices & PET scans 
Finally, with the third option all the information which it has been shown in the 
previous options can be visualized. In addition, the information about the diagnosis 
and the psychological tests, which are performed to the patients whose PET scans 
have been analyzed, are shown.  This visualization can be seen in figure 21: 
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Figure 21: PET scans and difference matrices visualization. 
 
On the right part of figure 21, all the information about the patient diagnosis is 
displayed, as well as, the results of the psychological tests which are performed to 
the patients. Furthermore, to know the parameters of each test, this application 
displays in small informative windows the values of each parameter for each 
psychological test. These informative windows appear when the name of the 
psychological test is clicked. 





Figure 22: Information about psychological tests visualization. 
 
In this way, all the information shown in this third option is helpful to analyze and 













Once the procedure to obtain the order among PET scans has been explained, it 
can be observed that, the obtained order among PET scans will depend on the 
values which will be established for the parameters 2 and 3. For this reason, this 
chapter will analyze which values will be the most appropriate for these 
parameters.  
To perform this analysis, two different approaches have been used. In the first 
approach, the best values for parameters 2 and 3 will be analyzed to order the 
PET scans of a particular patient who suffers Alzheimer’s disease. In this way, the 
brain metabolism degradation in Alzheimer`s disease will be particularly visualized. 
In the second approach, the best values for the parameters 2 and 3 will be 
analyzed to order a set of PET scans of different patients who have different 
diagnose (MCI and AD). In this way, the overall brain metabolism degradation in 
Alzheimer’s disease will be visualized. So, in both approaches, the analysis at slice 
level and at the whole brain level will be done. 
All the experiments done in each approach and the measures used to evaluate the 
orderings will be described in the first section of this chapter. The obtained results 
and the most appropriate values for the parameters 2 and 3 will be shown and 
discussed in the second section of this chapter. 
 
7.1 Experiment Settings 
Recalling that, the value of parameter 2 for two given PET scans will determine 
which of them will have more overlap area; and, the value of parameter 3 will 
determine if the affected areas of two PET scans are similar or not. The object of 
these experiments will be to obtain the ordering graphs for each pair of values of 
the parameters 2 and 3, and to evaluate these graphs by using the evaluation 
measures of each test. 
In each test, the ordering graphs will be evaluated by using the range of values 
from 10% to 90% for parameter 2, and the range of values from 0% to 20% for 







7.1.1 Patients History Test 
In this test, we evaluate which values for parameters 2 and 3 provide the best PET 
scans order from a particular patient, and therefore, the best visualization of the 
deterioration of metabolism in Alzheimer’s disease in a particular case.  
So, we see in the first section, which PET scans are analyzed, and in the second 
section, which evaluation measures are used to evaluate the order in this test. 
 
7.1.1.1 Experiments 
To achieve this test and its evaluation, we have used three sets of 6 PET scans 
from three different patients. So, we have applied the ordering procedure for each 
set of PET scans of each patient by using different values for the parameters 2 and 
3. In this way, we have obtained the corresponding ordering graphs. 
Given that in this test we have the original graphs of the PET scans by using their 
dates, we can do the comparison between the obtained graphs and the original 
graphs. So, by using the measures which we see in point 7.1.1.2, each obtained 
graph will be assessed in comparison with the original graph. In this way, the pair 
of values of the parameters 2 and 3, which will provide high scores, will be the 
most appropriate values for these parameters. Therefore with these values, the 
best orderings among PET scans of each patient will be obtained. 
 
7.1.1.2 Evaluation measures 
The measures that allow us to evaluate the obtained graphs in this test are: F-
measure, median and average. 
The measure F-measure evaluates the accuracy of the obtained graphs for each 
pair of values of the parameters 2 and 3. To apply this measure, two calculations 







The correct_connections are the connections that are in the original graph and 
also, in the obtained graph; the correct_connections_not_obtained, are the 
connections that are in the original graph but are not in the obtained graph; and 
finally, the obtained_connections_not_correct, are the connections that are in the 
obtained graph but are not in the original graph. 
Therefore, the measure F-measure has been calculated in the following way: 
 
 
Figure 23: Calculation of F-measure 
 
In this way, we have obtained the scores of the obtained graphs for each patient, 
and for each pair of values of the parameters 2 and 3. 
Finally, we have calculated the measures average and median. The values of 
these measures are done in the following way: 
 
Average: this calculation is done by using the next formula:  
 
Figure 24: Calculation of average 
 
Median: to calculate this value, we have followed these steps: 
1. Sort the values. 
2. Calculate the median by using the formula: ((n+1)/ 2), n is the number of 
values. 
In this way, we have obtained the values of median and average from the three 
values of F-measure which have been calculated for each pair of values of the 
parameters 2 and 3. The values of these measures allow us to know the middle 
values for each pair of the values of the parameters 2 and 3. Therefore, analyzing 
the values of median, average and F-measure for each pair of values of the 
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parameters 2 and 3, we will know which values are the most appropriate for these 
parameters to obtain a good order among PET scans of the diseased person, and 
therefore, a particularly good visualization of the brain metabolism degradation in 
Alzheimer’s disease. 
 
7.1.2 Disease degradation Test 
In this test, we evaluate which values for parameters 2 and 3 provide the best PET 
scans order from different patients, and therefore, a best visualization of the 
deterioration of metabolism in Alzheimer’s disease in a general way.  
So, we see in the first section, which PET scans are analyzed, and in the second 




To achieve this test and its evaluation, we have used a set of 77 PET scans from 
different patients who have different diagnose (MCI or AD). So, we have applied 
the ordering procedure to all set of PET scans by using different values for the 
parameters 2 and 3. In this way, we have obtained the corresponding ordering 
graphs. 
Given that in this test we do not have the history of PET scans for each patient, an 
original graph cannot be used to evaluate the obtained graphs for each pair of 
values of the parameters 2 and 3. Therefore in this test, we use some features of 
PET scans to obtain the scores of the obtained graphs for each pair of values of 
the parameters 2 and 3. In this way, the pair of values, for these parameters, that 
will provide high scores, will be the most appropriate values for these parameters, 
and therefore, we will obtain with them a good order among PET scans of the 
diseased people, and as a consequence, we will also obtain a good visualization of 
the overall brain metabolism degradation in Alzheimer’s disease.  
 
7.1.2.2 Evaluation measures 
Considering that we want to analyze the progress of the brain metabolism 
degradation in Alzheimer’s disease, we have selected as evaluation measures 
those features of PET scans which can represent this progress. 
So, we have used the diagnosis and the value of MMSE test as measures to 
evaluate the accuracy of the obtained graphs because both features show the 
state of dementia of the patients, whose PET scans are analyzed. This accuracy 
will represent the percentage of correct connections in the obtained graphs for 
each pair of values of the parameters 2 and 3. 
Given that the PET scans have the following diagnosis: 
- MCI: the patient suffers mild cognitive impairment but he/she does not 
develop Alzheimer’s disease. 
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- MCI_conv: the patient suffers mild cognitive impairment and he/she can 
develop Alzheimer’s disease. 
 
- AD: the patient suffers Alzheimer’s disease 







The value of MMSE test can decrease 1 or 2 points and it does not mean there is 
impairment in the brain metabolism. For this reason, we have introduced three 
types of tolerances to evaluate the values of MMSE test in the connections of the 
obtained graphs. These tolerances are the following: 
1) MMSE_prev >= MMSE_sig  
2) MMSE_prev+1 >= MMSE_sig 
3) MMSE_prev+2 >= MMSE_sig 
In this way, to analyze if a connection among two PET scans 
(PET_scan1PET_scan2) will be correct, we will compare the values of MMSE 
test for both PET scans. The value of MMSE test for the previous PET scan 
(PET_scan1) will be the MMSE_prev, and the value of MMSE test for the next PET 
scan (PET_scan2) will be the MMSE_sig.  
So, we evaluate which tolerance provides more correct connections in the obtained 
graphs for each pair of values of the parameters 2 and 3. To obtain this evaluation, 
the next values have been selected:  
- parameter 2 ϵ [10, 30] 
- parameter 3 ϵ [0, 20]  
In table 8 we show the results: 
P2 P3 SCORE_MMSE1 SCORE_MMSE2 SCORE_MMSE3 SCORE_DIAGNOSE SCORE_TOTAL CONNECTIONS 
10% 0%  72.32 80.51 87.158 61.84 55.57 1355 
10% 5% 74.49   82.64  89.48 62.22 56.96 1141 
10% 10% 75.45  83.15 89.53 62.93 57.280 831 
10% 20% 79.21 87.528 92.609 65.35 60.739 433 
20% 0% 74.48 81.609 88.39 64.94 58.62 870 
20% 5% 75.40 82.27 89.13 64.41 58.55 801 
20% 10% 75.71 83.096 89.488 64.06 58.238 704 
20% 20% 79.21 87.528 92.609 65.35 60.73 433 
30% 0% 73.60 82.52 88.475 65.24 58.73 538 
30% 5% 74.85 83.62 89.668 64.91 59.259 513 
30% 10% 75.10 84.23 90.248 64.73  59.33 482 
30% 20% 78.44 87.53 92.72 65.19 60.77 385 
 
Table 8: Scores for the tolerances of MMSE test 
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As we can analyze in table 8, the third tolerance is the one which obtains the 
highest scores. For this reason, we have selected tolerance 3 as the best tolerance 
to obtain good orderings among PET scans. 
Therefore, we consider as correct connections in the obtained graphs, the 
connections that fulfill the condition of diagnosis and the condition of the value of 
MMSE test using the third tolerance (MMSE_prev+2 >= MMSE_sig). In this way, 
the final scores will be the percentages of correct connections in each obtained 
graph for each pair of values of the parameters 2 and 3.  
So, analyzing the obtained scores for each pair of values of  these parameters, we 
will know which values will be the most appropriate to obtain a good order among 
PET scans of the diseased people, and therefore, a good visualization of the 
overall brain metabolism degradation in Alzheimer’s disease. 
 
7.2  Results and Discussion  
In this point, we see the scores of the ordering graphs which have been obtained 
for each pair of values of the parameters 2 and 3, and we discuss which values of 
these parameters are the most appropriate for each one of the performed tests. 
 
7.2.1 Patients history test 
In this type of test, we have evaluated each obtained graph by using the measure 
F-measure. This measure evaluates the accuracy of the obtained graphs regarding 
the original graph. Furthermore, for each pair of values of the parameters 2 and 3, 
the average and median are calculated to obtain the middle scores. In table 9, we 










007_S_0101 AVERAGE MEDIAN 
P2=10%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=10%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=10%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=10%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=20%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=20%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=20%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=20%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=30%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=30%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=30%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=30%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=40%     P3=0% 0,20 0,38 0,38 0,32 0,38 
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P2=40%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=40%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=40%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=50%     P3=0% 0,20 0,38 0,30 0,29 0,30 
P2=50%     P3=5% 0,21 0,35 0,25 0,27 0,25 
P2=50%     P3=10% 0,22 0,37 0,27 0,29 0,26 
P2=50%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=55%     P3=0% 0,20 0,25 0,25 0,23 0,25 
P2=55%     P3=5% 0,21 0,29 0,28 0,26 0,29 
P2=55%     P3=10% 0,22 0,31 0,31 0,28 0,31 
P2=55%    P3=20% 0,31 0,18 0,18 0,22 0,18 
P2=60%     P3=0% 0,20 0,15 0,15 0,17 0,15 
P2=60%     P3=5% 0,21 0,17 0,17 0,18 0,17 
P2=60%     P3=10% 0,22 0,18 0,18 0,19 0,18 
P2=60%     P3=20% 0,31 0,20 0,20 0,24 0,20 
P2=70%     P3=0% 0,20 0,17 0,17 0,18 0,17 
P2=70%     P3=5% 0,21 0,18 0,18 0,19 0,18 
P2=70%     P3=10% 0,22 0,20 0,20 0,21 0,20 
P2=70%     P3=20% 0,31 0,20 0,20 0,24 0,20 
P2=75%     P3=0% 0,22 0,18 0,18 0,19 0,18 
P2=75%     P3=5% 0,23 0,20 0,20 0,21 0,20 
P2=75%     P3=10% 0,25 0,22 0,22 0,23 0,22 
P2=75%     P3=20% 0,31 0,22 0,22 0,25 0,22 
P2=80%     P3=0% 0,22 0,22 0,22 0,22 0,22 
P2=80%     P3=5% 0,23 0,22 0,22 0,22 0,22 
P2=80%     P3=10% 0,25 0,22 0,22 0,23 0,22 
P2=80%     P3=20% 0,31 0,22 0,22 0,25 0,22 
P2=90%     P3=0% 0,25 0,25 0,25 0,25 0,25 
 
Table 9: Scores of the Patients History Test 
 
Analyzing table 9, it can be observed that all the calculated scores are below 1. 
Therefore, neither pair of values, for the parameters 2 and 3, provides an ordering 
like the original which has been obtained by using the date of the PET scans. So, 
we proceed to analyze which pair of values, for the parameters 2 and 3, shows the 
best orderings among PET scans. 
We will begin analyzing the most appropriate values for parameter 2, and then, we 
will analyze which values will be the most appropriate for parameter 3. In this way, 
the most appropriate range of values for these parameters will be established. This 
range will offer the best order among PET scans, and therefore, the best 





As we can see in table 9, the lowest scores, for parameter 2, are in the area of the 
percentages above 50%, and the highest scores are in the area of the percentages 
below 50%. Therefore, the percentages below 50% are the most appropriate for 
parameter 2, because with these values the best results have been obtained.  We 










007_S_0101 AVERAGE MEDIAN 
P2=10%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=10%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=10%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=10%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=20%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=20%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=20%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=20%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=30%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=30%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=30%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=30%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=40%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=40%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=40%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=40%     P3=20% 0,31 0,15 0,15 0,20 0,15 
P2=50%     P3=0% 0,20 0,38 0,3 0,29 0,30 
P2=50%     P3=5% 0,21 0,35 0,25 0,27 0,25 
P2=50%     P3=10% 0,22 0,37 0,27 0,29 0,26 
P2=50%     P3=20% 0,31 0,15 0,15 0,20 0,15 
 
Table 10: The best scores of the Patients History Test 
 
From table 10, it can be observed that for patient 007_S_0101, the best scores are 
in the area of percentages below 40% because with a 50% their scores are lower. 
So, we consider that percentage 50% does not guarantee good orderings for all 
patients. For this reason, this percentage is not an appropriate value for parameter 
2, and this can be discarded. 
Recalling the meaning of parameter 2, the percentages 10%, 20% and 30% are not 
restrictive conditions to evaluate the overlap areas of the PET scans. However, the 
percentage of 40% is a restrictive condition to evaluate the overlap areas of the 
PET scans. For this reason, we consider this percentage as the most appropriate 
for parameter 2 in this type of study. So, the most appropriate value for parameter 













007_S_0101 AVERAGE MEDIAN 
P2=40%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=40%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=40%     P3=10% 0,22 0,37 0,37 0,32 0,37 
P2=40%     P3=20% 0,31 0,15 0,15 0,20 0,15 
 
Table 11: The most appropriate values for parameter 2 in the Patients History Test. 
 
Once we know the most appropriate value for parameter 2 (table 11), we proceed 
with the analysis of the values for parameter 3. 
The value of parameter 3 determines if the overlap areas of two PET scans are 
similar or different. So, if the overlap areas are similar the value of parameter 3 will 
place these PET scans in the same level in the ordering graph. On the other hand, 
if the overlap areas are different, the value of parameter 3 will place the PET scan 
with more overlap area before the PET scan with less overlap area, in the ordering 
graph. In this way, the brain metabolism degradation can be visualized. 
Therefore, we see which values for parameter 3 provide the best results according 
to the value of 40% for parameter 2. 
Analyzing table 11, the lowest scores are obtained with the percentage of 20%, 
and the highest scores with the remaining percentages (0%, 5% and 10%). 
Therefore, we consider that the percentages below 20% are the most appropriate 










007_S_0101 AVERAGE MEDIAN 
P2=40%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=40%     P3=5% 0,21 0,35 0,35 0,31 0,35 
P2=40%     P3=10% 0,22 0,37 0,37 0,32 0,37 
 
Table 12: The most appropriate values for parameter 2 and parameter 3 in the Patients History 
Test. 
 
According to the meaning of parameter 3, we consider that the percentage of 0% is 
not a restrictive percentage to evaluate the difference between the overlap areas of 
PET scans, although with this percentage the results are better. So, with this 
percentage the ordering procedure does not take into account if the PET scans 




However, we consider that the percentage of 10% is more restrictive and the 
obtained orderings make more sense, although this percentage offers lower scores 
than the scores with a percentage of 0%. In this way, if the difference among the 
overlap areas of two PET scans is higher than 10%, this will mean that one of 
these PET scans provides more information about affected areas, and therefore, 
this PET scan should be posterior in the ordering graph.  
In contrast, if the difference is lower than 10%, this will mean that both PET scans 
provide the same information about affected areas, and therefore, these PET 
scans should be in the same level in the ordering graph. In the case that two PET 
scans have different affected areas, the difference among their overlap areas will 
be also low, and therefore, these PET scans should be also in the same level in 
the ordering graph because they will be showing different information about the 
brain metabolism degradation. 
So, with the percentage 10% for parameter 3, the brain metabolism degradation is 
better visualized. 
Given that with the percentage 0% we obtain better results than the percentage 
10%, we consider both values as the most appropriate values for parameter 3. 
Therefore, we conclude showing the most appropriate values for parameters 2 and 










007_S_0101 AVERAGE MEDIAN 
P2=40%     P3=0% 0,20 0,38 0,38 0,32 0,38 
P2=40%     P3=10% 0,22 0,37 0,37 0,32 0,37 
 
Table 13: Final values for parameters 2 and 3 in the Patients History Test. 
 
Given that the above values, for the parameters 2 and 3, are the ones which better 
scores provide, they cannot be considered the best values for these parameters 
because their scores are not high enough. To better understand if the above 
values provide good orderings for this approach, we will analyze the obtained 
graphs by using the values of table 13 for the parameters 2 and 3. 
So, we will evaluate the reason why the obtained graphs do not provide the same 
order as in the original graph. In addition, we will analyze the difference among 
obtained graphs according to the values of parameter 3 (0% and 10%) for the first 
patient and we will discuss which value is better. In this way, the ordering graphs 
of the other patients will be obtained by using the best value for parameter 3.  
We begin the study of the obtained graphs with patient 009_S_1030. So, we show 
the original graph which has been obtained by using the dates of PET scans of this 




Figure 25: Original Graph of Patient 009_S_1030 
 
As we can observe in figure 25, the structure of the original graph is a straight line 
because the order among PET scans is obtained according to their date. So, we 
will also analyze the structures of the obtained graphs, according to the values for 
parameters 2 and 3 of table 13. 
In the first place, we analyze the difference between the obtained graph with the 
values 40% and 0% for the parameters 2 and 3, and the original graph shown in 
figure 25. So, we see the obtained graph in figure 26: 
 
 
Figure 26: Ordering graph with p2=40% and p3=0% 
 
As we can observe in figure 26, this obtained graph also has the same structure 
than the original graph (figure 25). However, the connections between the nodes 2 
and 3, and the nodes 4 and 5 have opposite direction in relation to the original 
graph (figure 25). Therefore, we analyze the affected areas of these PET scans to 
understand why the ordering procedure has performed these connections in the 
obtained graph of figure 26. To do this, we use the images that show the affected 
areas of each PET scan. In the figures 27, 28, 29 and 30, we see the 









Figure 27: The affected areas of PET scan nº 3 (Patient: 009_S_1030) 
 
 
Figure 28: The affected areas of PET scan nº 2 (Patient: 009_S_1030) 
   
As we can observe, in both figures (27 and 28) the affected areas are the same. 
However, in figure 28, the affected areas are better appreciated and on the right 
part of the image, there is an affected area which cannot be observed in figure 27. 
For this reason, the ordering procedure has placed PET scan 2 after PET scan 3. 
Nevertheless, this connection is right because shows certain degradation in the 
brain metabolism. This degradation can be observed because PET scan 2 has 
more affected areas than PET scan 3.  
This connection is a clear example to explain why a high value for parameter 3 is 
better than a low value. In this example, the differences among these PET scans 
are small and their connection shows a small progression in the brain metabolism 
degradation. Therefore, with a high value for parameter 3 we will obtain a better 
order because the ordering procedure will place these PET scans at the same level 
in the ordering graph. We will see this when the order is done using the value 10% 
in parameter 3. 
Then, we analyze the affected areas of the PET scans 5 and 4 to better 








Figure 29: The affected areas of PET scan nº 5 (Patient: 009_S_1030) 
 
 
Figure 30: The affected areas of PET scan nº 4 (Patient: 009_S_1030) 
 
Analyzing the figures 29 and 30, we can appreciate that this connection shows a 
progression in the brain metabolism degradation, since PET scan 4 shows a 
greater affected area. Nevertheless, PET scan 4 was obtained before that PET 
scan 5. Analyzing both figures, we observe that at the top of figure 29 the affected 
area has increased. However, the affected area which appears at the bottom-right 
of figure 30 cannot be observed in figure 29. This can be because the used dose of 
the tracer to obtain PET scan 5 was lower than the dose used to obtain PET scan 
4. For this reason, the bottom-right affected area of figure 30 has not been 
detected in PET scan 5. Therefore, the ordering procedure has established PET 
scan 5 before PET scan 4 because this PET scan shows more affected areas than 
PET scan 5. 
So, once we have analyzed why the ordering procedure has placed the above 
connections in opposite direction in relation to the original graph (figure 25), we 
compare the ordering graph of figure 26 with the ordering graph obtained using the 




Figure 31: Ordering graph with p2=40% and p3=10% (Patient: 009_S_1030) 
 
Analyzing the figures 31 and 26, we observe that with a percentage of 10% for 
parameter 3, some PET scans are located at the same level in the graph, (PET 
scans 2, 3, 0 and 5). Moreover, with this percentage the structure of the graph is 
not a straight line but a directed graph. So, we will analyze if  the obtained graph of 
figure 31 will make more sense than the ordering graph of figure 26.  
As we can observe in figure 31, the PET scans 2, 3, 5, and 0 are at the same level 
in the graph. For this reason, we will analyze these PET scans to understand why 
they are at the same level in the graph, and why the PET scans 2 and 3 are in a 
previous level than the PET scans 0 and 5. Finally, we will analyze why PET scan 
1 is the root of the graph, as well as, why PET scan 4 is the last PET scan in the 
ordering graph of figure 31. 
In this way, in the first place we analyze the affected areas of the PET scans 2, 3, 
0 and 5 to understand their positions in the graph of figure 31. 
So, analyzing the figures 27 and 28, we see that the PET scans 2 and 3, show the 
affected areas in the same part of the brain. Although, PET scan 2 was obtained 
before than PET scan 3, their relation shows a poor progression in the brain 
metabolism degradation. For this reason, the ordering procedure has placed these 





On the other hand, analyzing the figures 29 and 32, we see that the PET scans 5 
and 0, show the affected areas in the same part of the brain. In addition, their 
relation also shows a poor progression in the brain metabolism degradation. For 
this reason, the ordering procedure has also placed these PET scans at the same 
level in the ordering graph of figure 31.  
 
 
Figure 32: The affected areas of PET scan nº 0 (Patient: 009_S_1030) 
 
So, analyzing the figures 27, 28, 29 and 32, we observe that the PET scans 2, 3, 5 
and 0 are at the same level in the ordering graph because they show similar 
overlap areas, that is to say, similar affected areas in the brain. Furthermore, the 
PET scans 2 and 3 are in a previous level because they show less informat ion 
about the brain metabolism degradation than the PET scans 5 and 0. Therefore, 
the visualization of the brain metabolism degradation makes more sense by using 
the percentage of 10% than with the percentage of 0% for parameter 3. So, the 
graph structure of figure 31 is better than the graph structure of figure 26. 
Finally, we analyze the affected areas of the PET scans 1 and 4 to understand why 
PET scan 1 is the root of the graph and why PET scan 4 is the last PET scan in the 
graph of figure 31. Their affected areas can be observed in the figures 30 and 33: 
 
 





Analyzing the figures 30 and 33, we observe that PET scan 4 shows more affected 
areas than the remaining PET scans which have been visualized, previously. 
Furthermore, this PET scan shows a greater impairment in the brain metabolism in 
the right part of the image. In relation to PET scan 1, this shows less affected 
areas than the rest of PET scans. For this reason, and after the procedure 
compares all the affected areas of all PET scans, the procedure has placed PET 
scan 1 as a root of the ordering graph and PET scan 4 as a leaf of the ordering 
graph. 
Therefore, we analyze the obtained graphs for the rest of the patients by using the 
values 40% and 10% for the parameters 2 and 3, respectively.  
We continue the analysis of the obtained graphs with patient 007_S_0128. In 




Figure 34: Original Graph of Patient 007_S_0128 
 
As we can observe in figure 34, the PET scans of this patient are very similar, and 
therefore, this is a hard example to obtain a good order among PET scans. 
Nevertheless, we analyze which ordering among the PET scans of this patient has 
been obtained by using the values 40% and 10% for the parameters 2 and 3, 




Figure 35: Ordering graph with p2=40% and p3=10% (Patient 007_S_0128) 
 
As we can appreciate in figure 35, the PET scans 2, 0 and 5 are at the same level 
in the graph. So, we will analyze why the ordering procedure has placed these PET 
scans in this level. Moreover, we will analyze why the ordering procedure has 
placed PET scan 5 before PET scan 1, if in the original graph (figure 34) this 
connection has an opposite direction. Finally, we will analyze why PET scan 4 is 
the root of the graph and PET scan 3 is the last PET scan in the ordering graph of 
figure 35. 
Then, we study the affected areas of the PET scans 2, 0 and 5 to understand why 
they are at the same level in the graph of figure 35. For this, we show the images 




Figure 36: The affected areas of PET scan nº 0 (Patient 007_S_0128) 
 
 
Figure 37: The affected areas of PET scan nº 2 (Patient 007_S_0128) 
 
 
Figure 38: The affected areas of PET scan nº 5 (Patient 007_S_0128) 
 
The three PET scans show the same affected areas at the bottom of the images 
(36, 37 and 38). Furthermore, the differences among these PET scans are small, 
and their relation shows a poor evolution in the brain metabolism degradation. 
Therefore, all these are enough conditions to place these PET scans at the same 




Then, we study why the ordering procedure has placed PET scan 5 before PET 
scan 1, since PET scan 1 was obtained before PET scan 5. So, we see which 
affected areas show each of them in the figures 38 and 39: 
 
Figure 39: The affected areas of PET scan nº 1 (Patient 007_S_0128)   
 
Analyzing the figures 38 and 39, we observe that figure 38 shows the affected 
areas at the bottom of the image better than figure 39. This makes sense because 
PET scan 5 was obtained after PET scan 1, and therefore, the affected areas of 
figure 38 indicate more impairment in the brain metabolism. However, the area 
which appears at the top-left of the images is bigger in figure 39 than in figure 38. 
In this case, we can suppose that the dose of tracer used to obtain PET scan 5 has 
not been enough to show the whole affected area which is observed in PET scan 
1. For this reason, the distinction of these areas has provoked that the ordering 
procedure considers PET scan 1 before PET scan 5. 
Finally, we study the affected areas of the PET scans 4 and 3 to understand why 
PET scan 4 is the root of the graph and PET 3 is the leaf of the graph. In this way, 
first we show the images of their affected areas in the figures 40 and 41: 
      





   Figure 41: The affected areas of PET scan nº 3 (Patient 007_S_0128) 
 
At the top-left of figure 40, the affected area is visualized with more intensity than 
in figure 41. However, the affected areas at the bottom of figure 40 are visualized 
with less intensity than the rest of PET scans. This provokes that PET scan 4 
provides less affected areas than the remaining PET scans, and as a consequence 
this PET scan has been placed as a root of the graph. 
In figure 41, the affected areas at the bottom of the images are visualized with less 
intensity than in figure 40. However, we can observe more affected areas at the 
top-right than in figure 40. This provokes that PET scan 3 has more affected areas 
than the remaining PET scans. For this reason, the ordering procedure has placed 
this PET scan as a leaf of the graph. 
Finally, the last patient in the analysis of the obtained graphs is patient 
007_S_0101. So, in figure 42, we show the original graph according to the date of 
the PET scans of this patient. 
 
 






We analyze which ordering among PET scans of this patient has been obtained by 
using the values 40% and 10% for the parameters 2 and 3, respectively. We see 
this ordering in figure 43: 
 
Figure 43: Ordering graph with p2=40% and p3=10% (Patient 007_S_0101) 
 
Comparing the graph of figure 43 with the original graph (figure 42), we observe 
that the following connections are fulfilled: 10, 03 and 42. 
In this way, we will analyze the PET scans 0, 4 and 5 to understand why the 
ordering procedure has placed these PET scans at the same level in the graph of 
figure 43. In addition, we will analyze the PET scans 3 and 2 to visualize the brain 
metabolism degradation that the connections 03, 52 and 43 will offer. 
Finally, we will analyze PET scan 1 to check its affected areas, since this is the 
first PET scan of the patient and also, the root of the ordering graph shown in 
figure 43. 
Then, we examine the affected areas of the PET scans 0, 4 and 5 to understand 
their position in the ordering graph of figure 43. We see their affected areas in the 





Figure 44: The affected areas of PET scan nº 0 (Patient 007_S_0101) 
 
 
Figure 45: The affected areas of PET scan nº 4 (Patient 007_S_0101) 
 
 
Figure 46: The affected areas of PET scan nº 5 (Patient 007_S_0101) 
 
Analyzing the figures 44, 45 and 46, we observe that the PET scans 0, 4 and 5 
show a common affected area at the bottom of these figures, but the progression 
of the brain metabolism degradation is different in each PET scan. In this way, we 
cannot establish connections among them because they do not show a relation 
among brain metabolism degradations. For this reason, the ordering procedure has 
placed these threes PET scans at the same level in the ordering graph of figure 43. 
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Then, we see the connections: 03, 52 and 43, to analyze the brain 
metabolism degradation which is offered for each one of these connections. 
The connection between PET scan 0 and PET scan 3 shows the brain metabolism 
degradation visualized in the figures 44 and 47. So, we analyze these figures to 
understand why the graph of figure 43 has established this connection. 
 
 
Figure 47: The affected areas of PET scan nº 3 (Patient 007_S_0101) 
 
Analyzing the figures 44 and 47, we observe that the PET scans 0 and 3 show the 
same affected areas. However, in this connection we can observe a progression in 
the brain metabolism degradation because in PET scan 3 the affected areas are 
more increased. Therefore, their connection is correct, and moreover is a real 
connection because it also appears in the original graph (figure 42). In this way, we 
can confirm that when the affected areas are well visualized, the ordering 
procedure establishes real connections among PET scans. 
The connection between PET scan 5 and PET scan 2 shows the brain metabolism 
degradation visualized in the figures 46 and 48. So, we analyze these figures to 
understand why the graph of figure 43 has established this connection. 
 
 




Analyzing the figures 46 and 48, we observe that the PET scans 5 and 2 also show 
the same affected areas. Furthermore, they visualize a progression in the brain 
metabolism degradation because in PET scan 2 the affected areas are more 
increased. So, these areas show a greater impairment in the brain metabolism. For 
this reason, the ordering procedure has placed PET scan 2 after PET scan 5. In 
this case, this connection is also correct and the order of the original graph (figure 
42) is also fulfilled. 
The connection between the PET scans 4 and 3 does not fulfill the established 
order in the original graph (figure 42). So, analyzing the figures 45 and 47, we 
observe that the PET scans 4 and 3 show the brain metabolism degradation in the 
central zone of the images. In this case, PET scan 4 was obtained after PET scan 
3, and therefore, the affected areas at the bottom of the image are more visualized 
in figure 45 than in figure 47. However, analyzing the figures 45 and 47, we 
observe that PET scan 3 shows more affected areas than PET scan 4. For this 
reason, the ordering procedure has placed PET scan 4 before than PET scan 3.  




Figure 49: The affected areas of PET scan nº 1 (Patient 007_S_0101) 
 
In figure 48 we observe that PET scan 1 has less affected areas than the rest of 
PET scans. This makes sense because PET scan 1 is the first PET scan of the 
patient, and therefore, its position in the graph of figure 43 is correct. Furthermore, 
this is also a real position according to the date of this PET scan.  
Therefore, we can conclude that analyzing the images of affected areas, the 
ordering graph obtained by the ordering procedure is better understood. 
Furthermore, with these images we can better understand why the obtained graphs 
are different in relation to the original graph.  
Then, we study which are the most appropriate values for the parameters 2 and 3 
when the whole brain is analyzed. In table 14 we see the scores obtained in this 
study and we will know if the values of these parameters are the same as in table 













007_S_0101 AVERAGE MEDIAN 
P2=10%     P3=0% 0,30 0,20 0,30 0,27 0,30 
P2=10%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=10%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=10%     P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=20%     P3=0% 0,30 0,20 0,30 0,27 0,30 
P2=20%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=20%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=20%     P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=30%     P3=0% 0,30 0,20 0,30 0,27 0,30 
P2=30%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=30%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=30%     P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=40%     P3=0% 0,30 0,20 0,30 0,27 0,30 
P2=40%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=40%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=40%     P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=50%     P3=0% 0,30 0,20 0,30 0,27 0,3 
P2=50%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=50%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=50%     P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=55%     P3=0% 0,30 0,20 0,30 0,27 0,3 
P2=55%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=55%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=55%    P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=60%     P3=0% 0,30 0,20 0,30 0,27 0,30 
P2=60%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=60%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=60%     P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=70%     P3=0% 0,30 0,20 0,24 0,25 0,24 
P2=70%     P3=5% 0,21 0,20 0,25 0,22 0,21 
P2=70%     P3=10% 0,25 0,24 0,29 0,26 0,25 
P2=70%     P3=20% 0,33 0,36 0,31 0,33 0,33 
P2=75%     P3=0% 0,30 0,20 0,13 0,21 0,20 
P2=75%     P3=5% 0,21 0,20 0,14 0,18 0,20 
P2=75%     P3=10% 0,25 0,24 0,15 0,22 0,24 
P2=75%     P3=20% 0,33 0,36 0,17 0,29 0,33 
P2=80%     P3=0% 0,33 0,11 0,20 0,21 0,20 
P2=80%     P3=5% 0,23 0,11 0,20 0,18 0,20 
P2=80%     P3=10% 0,28 0,13 0,22 0,21 0,22 
P2=80%     P3=20% 0,33 0,20 0,22 0,25 0,22 
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P2=90%     P3=0% 0,28 0,16 0 0,15 0,16 
 
Table 14: Scores of the Patients history test analyzing the whole brain. 
 
From table 14, we observe that the lowest scores are in the area of the 
percentages above 60%. So, with these percentages the best results have not 
been obtained, and therefore, we can discard them because they are not 
appropriate for the parameter 2.  
Analyzing the area of the percentages below 60% in table 14, we observe that all 
the scores are the same. That could be because the PET scans could have a lot of 
overlap area, and these values for parameter 2 are small enough. For this reason, 
we can consider that the percentages of 55% and 60% are the most restrictive to 
the condition of parameter 2, and therefore, the most appropriate if we want to 
obtain good orderings among PET scans by analyzing the whole brain. So, we 
show in table 15 the most appropriate values for parameter 2: 
 
VALUES PARAMETERS 








007_S_0101 AVERAGE MEDIAN 
P2=55%     P3=0% 0,30 0,20 0,30 0,27 0,30 
P2=55%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=55%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=55%    P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=60%     P3=0% 0,30 0,20 0,30 0,27 0,3 
P2=60%     P3=5% 0,21 0,20 0,33 0,25 0,21 
P2=60%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=60%     P3=20% 0,33 0,36 0,43 0,37 0,36 
 
Table 15: The most appropriate values for parameter 2 in the Patients history test analyzing 
the whole brain. 
 
Finally, analyzing the scores according to the values of parameter 3 in table 15, we 
observe that, with the percentages 10% and 20% we have obtained the highest 
scores. So, with these values the best orderings among PET scans have been 
obtained.  
Therefore, the most appropriate values for the parameters 2 and 3 in the analysis 














007_S_0101 AVERAGE MEDIAN 
P2=55%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=55%    P3=20% 0,33 0,36 0,43 0,37 0,36 
P2=60%     P3=10% 0,25 0,24 0,37 0,29 0,25 
P2=60%     P3=20% 0,33 0,36 0,43 0,37 0,36 
 
Table 16: The best values for parameter 2 and parameter 3 in the Patients history test 
analyzing the whole brain. 
 
In this study, we observe that sometimes the dose of tracer used in the obtention 
of PET scans is not the same and that is why, the affected areas of the PET scans 
are not shown very well in all the PET scans. For this reason, the orderings among 
PET scans do not provide the same order than the original ordering according to 
the date of the PET scans. Nevertheless, analyzing the images of affected areas, 
the obtained orderings among PET scans are good. 
In this way, we can conclude that the orderings among PET scans (figures 31, 35 
and 43) are quite good for the most appropriate values of the parameters 2 and 3 
when one slice of the PET scans is analyzed. In this way, using these graphs 
(figures 31, 35 and 43) we can show particularly the brain metabolism degradation 
in the development of Alzheimer’s disease. 
On the other hand, the analysis at the whole brain level is more complicated to do 
because it is a 3-dimensional analysis. For this reason, in this study the analysis 
using one slice of the PET scans has been done in more detail.  
 
7.2.2 Disease degradation test 
In this test, we have analyzed 77 PET scans and we have used the features of 
these PET scans (diagnose and value of MMSE test), to evaluate the obtained 
graphs according to the values of the parameters 2 and 3. In this evaluation, we 
have calculated a percentage of the connections which fulfill the conditions about 
diagnose and the value of MMSE test. These percentages have been calculated 
regarding to the total connections which have been established in the graph 
according to the values for the parameters 2 and 3.  
In table 17 the obtained scores are shown: 
 
P2 P3 SCORE_MMSE3 SCORE_DIAGNOSE TOTAL_SCORE CONNECTIONS 
10% 0% 87.16 61.84 55.57 1355 
10% 5%  89.48 62.22 56.96 1141 
10% 10% 89.53 62.93 57.28 831 
10% 20% 92.61 65.35 60.74 433 
20% 0% 88.39 64.94 58.62 870 
20% 5% 89.13 64.41 58.55 801 
82 
 
20% 10% 89.49 64.06 58.24 704 
20% 20% 92.61 65.35 60.73 433 
30% 0% 88.48 65.24 58.73 538 
30% 5% 89.67 64.91 59.26 513 
30% 10% 90.25 64.73  59.33 482 
30% 20% 92.72 65.19 60.77 385 
40% 0% 88.59 67.42 60.91 307 
40% 5% 89.03 66.77 60.79 301 
40% 10% 90.34 67.24 61.72 290 
40% 20% 90.80 67.43 61.68 261 
50% 0% 91.11 71.11 65.00 180 
50% 5% 91.01 70.78 64.60 178 
50% 10%  91.47 70.45 64.77 176 
50% 20% 92.53 70.68 65.51 174 
55% 0% 89.21 71.94 64.03 139 
55% 5% 89.13 71.74 63.77 138 
55% 10% 89.70 71.32 63.97 136 
55% 20% 90.37 71.11 64.44 135 
60% 0% 92.08 68.32  63.36 101 
60% 5% 92.00 68.00 63.00 100 
60% 10% 92.00 68.00 63.00 100 
60% 20% 92.00 68.00 63.00 100 
70% 0% 93.10 72.41 67.24 58 
70% 5% 93.10 72.41 67.24 58 
70% 10% 93.10 72.41 67.24 58 
70% 20% 93.10 72.41 67.24 58 
75% 0% 95.55 71.11 66.66 45 
75% 5% 95.55 71.11 66.66 45 
75% 10% 95.55 71.11 66.66 45 
75% 20% 95.55 71.11 66.66 45 
80% 0% 96.66 73.33  70.0 30 
80% 5% 96.66 73.33  70.0 30 
80% 10% 96.66 73.33  70.0 30 
80% 20% 96.66 73.33  70.0 30 
90% 0% 100.0 80.95 80.95 21 
 
Table 17: Scores of the Disease degradation test 
 
To better understand table 17 we detail the meaning of each column:  
-  “score_mmse3”: this column contains the percentage of connections 




-  “score_diagnose”: this column contains the percentage of connections 
which fulfill the diagnosis condition; 
 
-  “total_score”: this column contains the percentage of connections that 
fulfill the MMSE test condition and the diagnosis condition;  
 
-  “connections”: this column contains the total connections which have 
been established in the graph for each pair of values of the parameters 2 
and 3. 
Once the columns of table 17 have been described, we proceed to the analysis of 
the most appropriate values for the parameters 2 and 3. We will begin analyzing 
the most appropriate values for parameter 2, and then, we will analyze which 
values will be the most appropriate for parameter 3. In this way, the most 
appropriate range of values for these parameters will be established. This range 
will offer the best order among PET scans, and therefore, the best visualization of 
the overall brain metabolism degradation in Alzheimer’s disease.  
Analyzing table 17, we observe that in the column “total_score” the highest 
values are in the area of percentages above 55%. However, in this area the 
number of total connections is enough small, and as a consequence, the number 
of correct connections is lower than the total of PET scans which have been 
analyzed. Therefore, the area of percentages above 55% does not offer 
appropriate values for parameter 2. Table 18 shows the best values for parameter 
2: 
 
P2 P3 SCORE_MMSE3 SCORE_DIAGNOSE SCORE_TOTAL CONNECTIONS 
10% 0% 87.158 61.84 55.57 1355 
10% 5%  89.48 62.22 56.96 1141 
10% 10% 89.53 62.93 57.280 831 
10% 20% 92.609 65.35 60.739 433 
20% 0% 88.39 64.94 58.62 870 
20% 5% 89.13 64.41 58.55 801 
20% 10% 89.488 64.06 58.238 704 
20% 20% 92.609 65.35 60.73 433 
30% 0% 88.475 65.24 58.73 538 
30% 5% 89.668 64.91 59.259 513 
30% 10% 90.248 64.73  59.33 482 
30% 20% 92.72 65.19 60.77 385 
40% 0% 88.59 67.42 60.91 307 
40% 5% 89.03 66.77 60.79 301 
40% 10% 90.34 67.24 61.72 290 
40% 20% 90.80 67.43 61.68 261 
50% 0% 91.11 71.11 65.0 180 
50% 5% 91.011 70.78 64.60 178 
50% 10%  91.47 70.45 64.77 176 
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50% 20% 92.528 70.68 65.51 174 
55% 0% 89.208 71.94 64.028 139 
55% 5% 89.13 71.739 63.768 138 
55% 10% 89.70 71.32 63.97 136 
55% 20% 90.37 71.11 64.444 135 
 
Table 18: The best values for parameter 2 in the Disease degradation test 
 
Analyzing table 18, we observe that with the percentages 50% and 55% we have 
obtained the highest scores. However, analyzing the number of total connections 
and evaluating the percentages of correct connections, we obtain less correct 
connections in relation to the total connections. In this case, some PET scans 
cannot be connected. Therefore, the percentages 50% and 55% are not 
appropriate for parameter 2 so we can discard them. 
In this way, the most appropriate values for parameter 2 are in the area of 
percentages below 40%. We can see these values in table 19: 
 
P2 P3 SCORE_MMSE3 SCORE_DIAGNOSE SCORE_TOTAL CONNECTIONS 
10% 0% 87.158 61.84 55.57 1355 
10% 5%  89.48 62.22 56.96 1141 
10% 10% 89.53 62.93 57.280 831 
10% 20% 92.609 65.35 60.739 433 
20% 0% 88.39 64.94 58.62 870 
20% 5% 89.13 64.41 58.55 801 
20% 10% 89.488 64.06 58.238 704 
20% 20% 92.609 65.35 60.73 433 
30% 0% 88.475 65.24 58.73 538 
30% 5% 89.668 64.91 59.259 513 
30% 10% 90.248 64.73  59.33 482 
30% 20% 92.72 65.19 60.77 385 
40% 0% 88.59 67.42 60.91 307 
40% 5% 89.03 66.77 60.79 301 
40% 10% 90.34 67.24 61.72 290 
40% 20% 90.80 67.43 61.68 261 
 
Table 19: The most appropriate values for parameter 2 in the Disease degradation Test 
 
From table 19 we evaluate which values for parameter 3 offer the best results. 
The value of parameter 3 determines if the overlap areas of two PET scans are 
similar or different. So, if the overlap areas are similar the value of parameter 3 will 
place these PET scans in the same level in the ordering graph. On the other hand, 
if the overlap areas are different, the value of parameter 3 will place the PET scan 
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with more overlap area before the PET scan with less overlap area, in the ordering 
graph. In this way, the brain metabolism degradation can be visualized. 
Analyzing table 19, we observe that the highest scores are in the percentages 10% 
and 20%. However, analyzing the total connections, the percentages 0% and 5% 
offer more correct connections. Nevertheless, the percentages 10% and 20% are 
more restrictive than the percentages 0% and 5%. Therefore, with the percentages 
10% and 20% the PET scans with similar affected areas are located at the same 
level in the order. In this way, the obtained ordering graphs will be better.  
So, we show in table 20 the most appropriate values for the parameters 2 and 3: 
 
P2 P3 SCORE_MMSE3 SCORE_DIAGNOSE SCORE_TOTAL CONNECTIONS 
10% 10% 89.53 62.93 57.280 831 
10% 20% 92.609 65.35 60.739 433 
20% 10% 89.488 64.06 58.238 704 
20% 20% 92.609 65.35 60.73 433 
30% 10% 90.248 64.73  59.33 482 
30% 20% 92.72 65.19 60.77 385 
40% 10% 90.34 67.24 61.72 290 
40% 20% 90.80 67.43 61.68 261 
 
Table 20: The most appropriate values for parameter 2 and parameter 3 in the Disease 
degradation Test 
 
Given that there are a lot of connections among all 77 PET scans, it is difficult to 
show an ordering graph with all 77 PET scans. Therefore, we show an ordering 
among PET scans taking a set of them. 
In figure 50, we show the ordering among PET scans which has been obtained by 




Figure 50: An example of ordering graph for the Disease degradation test. 
 
In this approach, the ordering among PET scans of figure 50 cannot be compared 
with an original graph of the PET scans because we do not have the history about 
the date of PET scans. So, we can only analyze the number of correct connections 
in the obtained graph to evaluate its accuracy. 
As we can observe in table 20 the obtained graphs provide more correct 
connections when the condition of MMSE value is analyzed, than when the 
condition of diagnosis is evaluated. For this reason, when both conditions are 
evaluated the correct connections are lower. So, we can conclude that in the 
ordering among PET scans, there are more connections which fulfill the condition 
of MMSE value than connections which fulfill the condition of diagnosis.  
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The condition of diagnosis can be less fulfilled because some of the PET scans 
with serious diagnosis has been obtained after than other PET scans with less 
serious diagnosis, and therefore, the dose used in the obtention of the PET scans 
with serious diagnosis is lower than the dose used in the obtention of the PET 
scans with less serious diagnosis. That is why, the affected areas of the PET scan 
with serious diagnosis can be less appreciated than the affected areas of the other 
PET scans with less serious diagnosis, and therefore, when the ordering procedure 
analyses the overlap areas in two PET scans it locates the PET scan with more 
overlap area before than the other PET scan with less overlap area.  
On the other hand, the condition of the value of MMSE test can be more fulfilled 
because the value obtained by the patient in this test depends on some factors, 
such as, age, sex, education level. Therefore, in the graph we can find some PET 
scans with the same diagnosis and different values in MMSE test. 
This can be checked, analyzing some connections of the graph of figure 50. So, we 
analyze the next connections: 
The connection between PET scan 3 and PET scan 57 fulfills the condition of 
diagnosis and the condition of the value of MMSE test. In figures 51 and 52, the 
affected areas of these PET scans are shown: 
 
 
Figure 51: The affected areas of PET scan nº 3 (Graph figure 50) 
 
 




PET scan 3 has MCI_conv diagnosis and value 30 in MMSE test and PET scan 57 
has AD diagnosis and value 20 in MMSE test. So, the condition of diagnosis is 
fulfilled because PET scan 2 has a MCI_conv diagnosis which should be anterior 
to AD diagnosis. On the other hand, the condition of the MMSE test is also fulfilled 
because the MMSE values of both PET scans fulfill the third tolerance of MMSE 
test:  
MMSE_prev +2   the MMSE value of PET scan 3 +2 = 30+2=32 
MMSE_sig  MMSE value of PET scan 57 = 20 
3) MMSE_prev+2 >= MMSE_sig  32 >= 20  
For this reason, figure 52 shows more affected areas than figure 51. Furthermore, 
analyzing both figures, we observe that this connection shows the progress of the 
brain metabolism degradation in the middle of the brain. 
The connection between PET scan 3 and PET scan 36 does not fulfill the condition 
of the diagnosis but their values of MMSE test are decreased. In figures 51 and 53, 
the affected areas of these PET scans are shown. So, we analyze their affected 
areas, and then, we evaluate why PET scan 3 is before PET scan 36.  
 
 
Figure 53: The affected areas of PET scan nº 36 (Graph figure 50) 
 
Figure 53 represents PET scan 36 which has MCI diagnosis and value 28 in 
MMSE test. In this connection, the condition of diagnosis does not fulfill because 
PET scan 3 has MCI_conv diagnosis which should be posterior to MCI diagnosis of 
PET scan 36. On the other hand, in this connection the condition of MMSE test is 
fulfilled because the MMSE values of both PET scans fulfill the third tolerance of 
MMSE test: 
MMSE_prev +2   the MMSE value of PET scan 3 +2 = 30+2=32 
MMSE_sig  MMSE value of PET scan 36 = 28 




So, the reason of this connection could be that the dose used in the obtention of 
both PET scans is different. As we can observe, the affected areas in figure 53 are 
more visible than in figure 51. However, in figure 51 some affected area appears 
on the left part of the figure. So, we can conclude that the dose used in the 
obtention of PET scan 3 was lower than the dose used in PET scan 36. For this 
reason the affected areas in figure 53 are more visible than in figure 51, and 
therefore, the procedure has placed PET scan 3 before PET scan 36. 
Finally, we see a connection that fulfills the condition of the diagnosis but it does 
not fulfill the condition of the value of MMSE test. This is the connection between 
PET scan 57 and PET scan 7. In figures 52 and 54, the affected areas of these 
PET scans are shown. So, we analyze their affected areas, and then, we evaluate 
why PET scan 57 is before PET scan 7. 
 
 
Figure 54: The affected areas of PET scan nº 7 (Graph figure 50) 
 
Figure 54 represents PET scan 7 which has AD diagnosis and value 26 in MMSE 
test. In this connection the condition of diagnosis is fulfilled because both PET 
scans have AD diagnosis. On the other hand, in this connection the condition of 
the value of MMSE test does not fulfill because MMSE value of PET scan 57 is 20 
and MMSE value of PET scan 7 is 26, and therefore, they do not fulfill the third 
tolerance of MMSE test: 
 MMSE_prev +2   the MMSE value of PET scan 57 +2 = 20+2=22 
MMSE_sig  MMSE value of PET scan 7 = 26 
3) MMSE_prev+2 >= MMSE_sig  22 >= 26  
However, analyzing the figures 52 and 54 we can observe that at the top of figure 
54 the affected area has been increased; otherwise, figure 52 shows other affected 
areas that cannot be appreciated in figure 54. The reason could be that the dose 
used in the obtention of these PET scans is different. Nevertheless, the connection 
is correct because PET scan 7 has more degradation in the brain metabolism than 
PET scan 57. Therefore, the condition of the value of MMSE test does not fulfill 
because the patient of PET scan 7 could have a higher education level than the 
patient of PET scan 57. So, both patients have developed Alzheimer’s disease but 
one of them has obtained the best value in MMSE test. 
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Therefore analyzing these connections, we can observe that in this study, the 
doses used in the obtention of PET scans are also a problem to order the PET 
scans in a right way. However, we can conclude that the orderings among PET 
scans are quite good for the most appropriate values of the parameters 2 and 3 
when one slice of the PET scans is analyzed. In this way, the overall brain 
metabolism degradation in the development of Alzheimer’s disease can be shown.  
Then, we study which are the most appropriate values for the parameters 2 and 3 
when the whole brain is analyzed. In table 21 we see the scores obtained in this 
study and we will know if the values of these parameters are the same as in table 
20, or probably these values change in the analysis of the whole brain: 
 
P2 P3 SCORE_MMSE3 SCORE_DIAGNOSE SCORE_TOTAL CONNECTIONS 
10% 0% 87.29 63.57 57.69 1598 
10% 5% 89.35 63.09  57.68 1203 
10% 10% 91.95 62.42 58.77 684 
10% 20% 93.61 65.42 62.23 188 
20% 0%  86.14 66.14 59.37 635 
20% 5%  88.73 66.19 60.73 568 
20% 10% 91.08 64.80 61.28 483 
20% 20% 93.61 65.42 62.23 188 
30% 0% 86.25 69.16  61.66 240 
30% 5% 88.10 69.16 62.99 227 
30% 10% 89.42 67.78 62.98 208 
30% 20% 93.66 69.01 64.78 142 
40% 0% 92.31 71.79 66.60 78 
40% 5% 92.10 71.05 65.79 76 
40% 10% 93.05 69.44 65.27 72 
40% 20% 98.27 67.24 65.52 58 
50% 0% 83.33 70.83 54.16 24 
50% 5% 83.33 70.83 54.16 24 
50% 10% 86.95 69.56 56.52 23 
50% 20% 94.73 63.15 57.89 19 
55% 0% 80.00 73.30 53.30 15 
55% 5% 80.00 73.30 53.30 15 
55% 10% 80.00 73.30 53.30 15 
55% 20% 91.66 66.60 58.30 12 
60% 0% 100.00 60.00 60.00 5 
60% 5% 100.00 60.00 60.00 5 
60% 10% 100.00 60.00 60.00 5 
60% 20% 100.00 50.00 50.00 4 
70% 0% 100.00 100.00 100.00 1 
70% 5% 100.00 100.00 100.00 1 
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70% 10% 100.00 100.00 100.00 1 
70% 20% 100.00 100.00 100.00 1 
 
Table 21: Scores of the Disease degradation test analyzing the whole brain. 
 
Analyzing table 21, we observe that the highest scores are in the area of 
percentages above 30%. However, in this area the obtained graphs have few 
connections. Therefore, in these graphs we could find nodes which are not 
connected. For this reason, we can discard these values for parameter 2 because 
they do not offer good orderings among PET scans. 
So, the most appropriate values for parameter 2 in the analysis of the whole brain 
are shown in table 22: 
 
P2 P3 SCORE_MMSE3 SCORE_DIAGNOSE SCORE_TOTAL CONNECTIONS 
10% 0% 87.29 63.57 57.69 1598 
10% 5% 89.35 63.092  57.68 1203 
10% 10% 91.95 62.42 58.77 684 
10% 20% 93.61 65.42 62.23 188 
20% 0%  86.14 66.14 59.37 635 
20% 5%  88.73 66.19 60.73 568 
20% 10% 91.097 64.80 61.28 483 
20% 20% 93.61 65.42 62.23 188 
30% 0% 86.25 69.16  61.66 240 
30% 5% 88.10 69.16 62.99 227 
30% 10% 89.42 67.78 62.98 208 
30% 20% 93.66 69.01 64.78 142 
 
Table 22: The most appropriate values for parameter 2 in the Disease degradation test 
analyzing the whole brain. 
 
Then, we proceed with the analysis of the values for parameter 3.  
Analyzing table 22, we observe that the highest values are in the percentages 10% 
and 20%. Nevertheless, the total connections with these percentages are lower 
than with the percentages 0% and 5%. Given that the percentages 10% and 20% 
are more restrictive than 0% and 5%, the obtained orderings are better and make 
more sense. Therefore, we show in table 23 the most appropriate values for the 






P2 P3 SCORE_MMSE3 SCORE_DIAGNOSE SCORE_TOTAL CONNECTIONS 
10% 10% 91.95 62.42 58.77 684 
10% 20% 93.61 65.42 62.23 188 
20% 10% 91.097 64.80 61.28 483 
20% 20% 93.61 65.42 62.23 188 
30% 10% 89.42 67.78 62.98 208 
30% 20% 93.66 69.01 64.78 142 
 
Table 23: The most appropriate values for the parameters 2 and 3 in the Disease degradation 
test analyzing the whole brain. 
 
In this study, the analysis at the whole brain level is also more complicated to do 
because it is a 3-dimensional analysis. For this reason, in this study only the 




















In the realization of this work, we have implemented an application that allows us 
to visualize an ordering among the PET scans of patients who suffer Alzheimer’s 
disease. In this way, we have observed how the brain metabolism degradation is in 
the development of Alzheimer’s disease. 
To obtain the order among PET scans and visualize the brain metabolism 
degradation, we have used an ordering procedure. This procedure is based on the 
analysis of the PET scans areas which have some impairment in the brain 
metabolism. So, once we have obtained the order, we have evaluated the accuracy 
of this order using the psychological tests which are performed to the patients 
before or after to obtain the PET scan. 
Although, the used procedure offers a good ordering among PET scans, this 
ordering could be improved using, in addition, the results of psychological test in 
the order analysis. 
So, with the analysis done in this work and the obtained results, we get more 
information about the development of Alzheimer’s disease. However, the 
improvement of this work, could offer a greater accuracy in the information about 
the development of Alzheimer’s disease. So, we propose this improvement as a 
future work, since, this could help in the early diagnosis of the Alzheimer’s disease.  
Even though this study can help in the early diagnosis of the disease, more studies 
should be carried about Alzheimer’s disease, to achieve a common goal that is 
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